<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">93138</article-id>
<article-id pub-id-type="doi">10.7554/eLife.93138</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.93138.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Developmental Biology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>MAFB drives differentiation by permitting WT1 binding to podocyte specific promoters</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Massa</surname>
<given-names>Filippo M.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jian-Motamedi</surname>
<given-names>Fariba</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Šerys</surname>
<given-names>Marijus</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tison</surname>
<given-names>Amelie</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Loubat</surname>
<given-names>Agnès</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lacas-Gervais</surname>
<given-names>Sandra</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martin</surname>
<given-names>Luc</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Belahbib</surname>
<given-names>Hassiba</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sarrazin</surname>
<given-names>Sandrine</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sieweke</surname>
<given-names>Michael H.</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Schedl</surname>
<given-names>Andreas</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Université Côte d’Azur</institution>, Inserm, CNRS, iBV, Nice, 06108, <country>France</country></aff>
<aff id="a2"><label>2</label><institution>Université Côte d’Azur,</institution> CCMA, Nice, F-06108, France</aff>
<aff id="a3"><label>3</label><institution>Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden</institution>, <country>Germany</country></aff>
<aff id="a4"><label>4</label><institution>Aix Marseille University</institution>, CNRS, INSERM, CIML, Marseille, <country>France</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Daehn</surname>
<given-names>Ilse S</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Icahn School of Medicine at Mount Sinai</institution>
</institution-wrap>
<city>New York</city>
<country>United States of America</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Araújo</surname>
<given-names>Sofia J</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of Barcelona</institution>
</institution-wrap>
<city>Barcelona</city>
<country>Spain</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Corresponding author: Andreas Schedl Université Cote d’Azur iBV Parc Valrose 06108 Nice France email: <email>Andreas.Schedl@unice.fr</email> Tel.: ++33489150730</corresp>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2023-12-07">
<day>07</day>
<month>12</month>
<year>2023</year>
</pub-date>
<volume>12</volume>
<elocation-id>RP93138</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2023-10-17">
<day>17</day>
<month>10</month>
<year>2023</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2023-09-07">
<day>07</day>
<month>09</month>
<year>2023</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.09.06.555670"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2023, Massa et al</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Massa et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-93138-v1.pdf"/>
<abstract>
<title>Abstract</title><p>Podocytes are highly specialized cells, but their chromatin status and the precise molecular events leading to their differentiation remain poorly defined. Here we used ChIP-Seq analysis for H3K4me3, H3K4me1 and H3K27me3 to establish the histone methylation map in adult mouse podocytes. Our data demonstrate open chromatin across podocyte specific genes and reveals that genes expressed in the mesoderm lineage become actively repressed upon podocyte differentiation. To better understand the transcriptional control of podocyte differentiation, we studied the role of transcription factor MAFB. ChIP-Seq experiments and functional analysis in conditional knockout mice identified a set of direct MAFB targets including <italic>Nphs1</italic>, <italic>Nphs2, Vegfa</italic> and <italic>Tcf21</italic>. Loss of <italic>MafB</italic> led to the deposition of extracellular matrix, progressive foot process effacement, and kidney disease. ChIP experiments in knockout animals revealed that during development MAFB is essential for H3K4me3 methylation and the recruitment of WT1 to the promoters of the podocyte specific genes <italic>Nphs1</italic> and <italic>Nphs2</italic>. Taken together our data reveal the crucial function of MAFB by permitting chromatin accessibility at podocyte-specific genes during development and maintaining terminal differentiation in adults.</p>
</abstract>

</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Cellular differentiation relies on the combined action of transcriptional regulators that activate specific genes to give a cell type its characteristic traits. Epigenetic modifications, such as histone methylations modulate chromatin structure and thus strongly impact the ability of transcription factors to bind to DNA and activate downstream target genes. Depending on the type of protein modifications, histone marks can be activating (H3K4me3), enhancing (H3K4me1, H3K27ac) or suppressing (H3K27me3) <sup><xref ref-type="bibr" rid="c1">1</xref></sup>. Epigenetic marks are not static, but are shaped by developmental processes and cellular differentiation. Deposition of the repressive mark H3K27me3 involves the polycomb repressive complex 2 (PRC2) that has been shown to be essential for early embryonic development<sup><xref ref-type="bibr" rid="c2">2</xref></sup>. Removal of suppressive histone marks is achieved through specific enzymes that work together with so called pioneering factors that are able to access closed chromatin.</p>
<p>Podocytes are highly specialised cells that are crucial components of the glomerular filter. Differentiation of progenitors involves a number of transcription factors including members of the FOXC gene family <sup><xref ref-type="bibr" rid="c3">3</xref>–<xref ref-type="bibr" rid="c7">7</xref></sup>, LMX1B <sup><xref ref-type="bibr" rid="c4">4</xref>,<xref ref-type="bibr" rid="c8">8</xref>–<xref ref-type="bibr" rid="c10">10</xref></sup>, TCF21 <sup><xref ref-type="bibr" rid="c11">11</xref></sup>, the Wilms’ tumor homologue WT1 <sup><xref ref-type="bibr" rid="c12">12</xref>–<xref ref-type="bibr" rid="c18">18</xref></sup> and MAFB <sup><xref ref-type="bibr" rid="c19">19</xref>,<xref ref-type="bibr" rid="c20">20</xref></sup>. WT1 in particular has been shown to be essential for podocyte differentiation and as many as 50% of podocyte specific genes appear to be direct WT1 targets. Indeed, deletion of WT1 in adult mice leads to a rapid loss of podocyte specific gene expression and, as a consequence renal failure <sup><xref ref-type="bibr" rid="c14">14</xref>,<xref ref-type="bibr" rid="c22">22</xref></sup>. While WT1 is essential for the expression of podocyte specific genes such as nephrin (<italic>Nphs1</italic>) <sup><xref ref-type="bibr" rid="c23">23</xref></sup>, it is not sufficient for their activation. How WT1 can access enhancers and promoters and activate podocyte specific genes is presently poorly understood.</p>
<p>MAFB belongs to the family of large MAF proteins that are characterised by a basic domain involved in DNA binding, a leucine zipper structure that permits hetero and homo-dimerization and an acidic domain involved in transactivation of gene expression <sup><xref ref-type="bibr" rid="c24">24</xref>,<xref ref-type="bibr" rid="c25">25</xref></sup>. MAFB has originally been identified as the gene underlying the Kreisler mutation in mice <sup><xref ref-type="bibr" rid="c26">26</xref></sup>, a spontaneous mutant that results in defects of segmentation, brain patterning, pancreas development and macrophage differentiation (for review see <sup><xref ref-type="bibr" rid="c27">27</xref></sup>). Further analyses have revealed an important function for podocyte development and function <sup><xref ref-type="bibr" rid="c20">20</xref>,<xref ref-type="bibr" rid="c28">28</xref>,<xref ref-type="bibr" rid="c19">19</xref></sup>, and heterozygous point mutations in <italic>MAFB</italic> have been identified in patients suffering from FSGS and Duane retraction syndrome <sup><xref ref-type="bibr" rid="c21">21</xref></sup>, as well as in cases of multicentric carpotarsal osteolysis<sup><xref ref-type="bibr" rid="c29">29</xref></sup>, a syndrome that is associated with a high risk of developing chronic kidney disease. How MAFB contributes to podocyte differentiation and maintenance, as well as its direct targets in this cell type remain poorly defined.</p>
<p>Here we set out to perform an unbiased study of the epigenetic state of the fully mature podocytes and identify the genome wide targets of MAFB. By employing constitutive and inducible podocyte specific knockout animals, we show that MAFB is essential for the activation of the podocyte specific gene program, by opening chromatin and permitting WT1 to bind to promoters of podocyte specific genes such as <italic>Nphs1</italic> and <italic>Nphs2</italic>.</p>
</sec>
<sec id="s2">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Mice</title>
<p>Mice were housed in a conventional animal facility with free access to food and water. Deletion of <italic>MafB</italic> in fully differentiated podocytes was performed using the inducible <italic>Wt1:Cre<sup>ERT</sup></italic><sup><xref ref-type="bibr" rid="c2">2</xref></sup> line <sup><xref ref-type="bibr" rid="c30">30</xref></sup> in combination with the conditional <italic>Mafb<sup>LoxP/LoxP</sup></italic> <sup><xref ref-type="bibr" rid="c31">31</xref></sup> allele and the GFP reporter <italic>Rosa26R<sup>mTmG</sup></italic> (Ref. <sup><xref ref-type="bibr" rid="c30">30</xref></sup>). <italic>Mafb</italic> deletion was induced in adult male mice (8-10 weeks) with two consecutive days intraperitoneal injection of Tamoxifen (SIGMA) at 40mg/kg dissolved in corn oil. The developmental analysis was performed on E18.5 embryonic kidneys obtained by mating animals carrying the <italic>Mafb</italic><sup>GFP/+</sup> constitutive knockin allele <sup><xref ref-type="bibr" rid="c32">32</xref></sup>. All experiments were performed according to national guidelines and approved by the French Minister of Higher Education (APAFIS#22471-2019011513265550v8).</p>
</sec>
<sec id="s2b">
<title>Chromatin Immune Precipitation</title>
<p>Adult podocytes were isolated as previously described<sup><xref ref-type="bibr" rid="c33">33</xref></sup> with minor modifications. Briefly, glomeruli were isolated by paramagnetic beads perfusion and podocytes released by further digestion. Single cell suspension was then crosslinked with methanol-free Formaldehyde 1% (Thermofisher) for 10 minutes at RT before quenching, permeabilization and staining with anti-Podocin (SIGMA). Isolated podocytes were aliquoted in sonication buffer (50 mM HEPES pH 7.4, 1 mM EDTA, 150 mM NaCl, 0.4 % SDS, 1% Triton ×100, 1x protease inhibitor) and immediately sonicated using the sonicator Covaris S220 (peak incidence 150W, duty factor 10%, duration 20 minutes). For the epigenetic analysis during kidney development, whole kidneys were isolated from E18.5 embryos, crosslinked, mechanically dissociated in sonication buffer and sonicated with the previous parameters. Chromatin immuno-precipitation was performed using 200000 cells per condition (adult podocytes) or 3µg of chromatin per condition (immature podocytes) in combination with the following kit, reactives and antibodies from Diagenode, if not otherwise specified: True MicroChip-seq kit (ref. C01010132), anti-H3K4me3 (ref. C15410030), anti-H3K4me1 (ref. C15410037), anti-H3K27me3 (ref. C15410195), rabbit IgG (C15410206), anti WT1 (SantaCruz, ref. sc192), anti MAFB, (SIGMA, ref. HPA005653). Libraries were synthetized from the obtained chromatin using the MicroPlex Library Preparation Kit v2 (ref. C05010013) and sequenced.</p>
<p>Bionformatic analysis was performed on two independent biological replicates for each epigenetic mark or transcription factor using Galaxy based approaches (<ext-link ext-link-type="uri" xlink:href="http://usegalaxy.org">http://usegalaxy.org</ext-link>). Trimmed, groomed reads were aligned to the reference genome mm10 and the peaks were called using the MACS2 algorithm (FDR&lt;0.05). WT1 and MAFB ChIP peaks were further refined using IDR&lt;0.01 and IDR&lt;0.05, respectively, as a threshold. The datasets obtained were further polished with the exclusion of blacklisted loci recently published. For histone marks no IDR analysis was performed but enriched regions consistent between both datasets were considered as peaks. MEME analysis <sup><xref ref-type="bibr" rid="c34">34</xref></sup> (<ext-link ext-link-type="uri" xlink:href="http://meme-suite.org">http://meme-suite.org</ext-link>) was carried out to define <italic>de novo</italic> consensus binding regions and search for other TF binding sites using <italic>in silico</italic> databases. GREAT algorithm <sup><xref ref-type="bibr" rid="c35">35</xref></sup> (<ext-link ext-link-type="uri" xlink:href="http://bejerano.stanford.edu/great/public/html/">http://bejerano.stanford.edu/great/public/html/</ext-link>) was used to analyze the gene ontology terms correlated with the regions bound by the transcription factors or the modified histones. Heat maps and genomic tracks were generated using the Easeq software <sup><xref ref-type="bibr" rid="c36">36</xref></sup>.</p>
<p>H3K4me3 enrichment in embryonic kidneys was assessed by RT-qPCR. Immunoprecipitated chromatin was purified and the enrichment for <italic>Nphs1</italic>, <italic>Nphs2</italic> and <italic>Synpo</italic> promoters was compared against IgG ChIP experiments and regions distant from the discovered peaks. Primers sequences used for the RT-qPCR are listed in Suppl. Table 5.</p>
</sec>
<sec id="s2c">
<title>Gene expression analysis</title>
<p>RNA-seq analysis was performed on FACS-sorted isolated podocytes. Kidneys were harvested from 8 weeks old mice, 2 days after tamoxifen induction. Podocytes were isolated using previously described protocols<sup><xref ref-type="bibr" rid="c33">33</xref></sup> and taking advantage of the <italic>Rosa26R</italic> mTmG reporter. In brief, GFP+ (recombined) podocytes were sorted by FACS from dissociated kidneys and isolated cells immediately processed with RNeasy micro kit (Qiagen) to obtain purified total RNA. A total of 5 samples for control (<italic>Mafb<sup>LoxP/+</sup>; WT1 Cre <sup>ERT</sup></italic><sup><xref ref-type="bibr" rid="c2">2</xref></sup><italic>; Rosa26<sup>mTmG</sup></italic>) and KO (<italic>Mafb<sup>LoxP/LoxP</sup>; WT1 Cre <sup>ERT</sup></italic><sup><xref ref-type="bibr" rid="c2">2</xref></sup><italic>; Rosa26<sup>mTmG</sup></italic>) were selected. RNAs were quality assessed (Agilent 2100 Bioanalyzer, RIN&gt;9) and RNA libraries were prepared using NEBNext® Ultra TM RNA Library Prep Kit for Illumina® (NEB, USA) following manufacturer’s protocols. The clustering of the index-coded samples was performed by Novogene on a cBot Cluster Generation System using PE Cluster Kit cBot-HS (Illumina). Paired-end clean reads were mapped to the reference genome using HISAT2 software and for samples with biological replicates, differential expression analysis of two conditions/groups was performed using the DESeq2 R package.</p>
<p>Single cell analysis in <xref rid="fig4" ref-type="fig">Fig. 4B</xref> was performed using the fetal nephron dataset from <sup><xref ref-type="bibr" rid="c37">37</xref></sup> in the publicly available database (<ext-link ext-link-type="uri" xlink:href="https://cellxgene.cziscience.com/e/08073b32-d389-41f4-a4fd-616de76915ab.cxg/">https://cellxgene.cziscience.com/e/08073b32-d389-41f4-a4fd-616de76915ab.cxg/</ext-link>).</p>
</sec>
<sec id="s2d">
<title>Tissue analysis, histology, EM analysis</title>
<p>Immune-fluorescence and histological analyses were performed on renal tissue, embedded in paraffine after fixation ON at 4°C with PFA 4%, and sectioned at 5um thickness. Primary antibodies used in the study included: anti-WT1 (Dako, ref M3561, clone 6F-H2), anti-MAFB (BETHYL Laboratories, ref IHC-00351), anti-NPHS1 (R&amp;D Systems, ref AF3159), anti-NPHS2 (Sigma, ref P0372), anti-SYNPO (PROGEN Biotechnik, ref 65194).</p>
<p>Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) analyses were performed essentially as described <sup><xref ref-type="bibr" rid="c12">12</xref>,<xref ref-type="bibr" rid="c38">38</xref></sup>. For the quantification of foot process effacement and glomerular basal membrane expansion, 3 animals per genotype were analyzed, using 20 images per animal containing an average of 1.33 basal membrane transversal sections. The basal membrane thickness was measured every two micrometers along each section, whereas the diameters of the foot processes was assessed for each event present along each segment.</p>
</sec>
<sec id="s2e">
<title>Urine analysis</title>
<p>Spot urines were collected at the same hour of the day (10 am) and centrifuged to eliminate aggregates and impurity. 5ul of the urines for each sample and time point was loaded in denaturing/reducing buffer (1x Laemmli) in 10% acrylamide/bis acrylamide gel and resolved by electric field. The gel was then stained by Blue Coomassie solution for 3 hours and destained until proper contrast was achieved.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Determining the histone profile in adult mouse podocytes</title>
<p>Epigenetic marks are highly cell type specific and it is therefore essential to start with pure cell populations to map histone modifications. To achieve this goal we isolated glomeruli from perfused adult mice, dissociated them into single cells and FACS sorted them based on the expression of podocin <sup><xref ref-type="bibr" rid="c33">33</xref></sup> (<xref rid="fig1" ref-type="fig">Fig. 1A</xref>). ChIP-Seq experiments (GEO GSE233911) for H3K4me3 (active), H3K4me1 (primed) and H3K27me3 (repressed) were carried out to determine the genome wide chromatin status in podocytes under homeostatic conditions. Biological duplicates showed highly reproducible peaks (<xref rid="figs1" ref-type="fig">Suppl. Figure 1A&amp;B</xref>) and all further analyses were therefore carried out with a merged data set. Heat maps across a set of podocyte-specific genes (Suppl. Table 1: GSE119531) <sup><xref ref-type="bibr" rid="c39">39</xref></sup> showed the expected histone methylation patterns with strong H3K4me3 at the transcription start site (TSS), enrichment of H3K4me1 in the gene body and depletion of H3K27me3 throughout expressed loci (<xref rid="fig1" ref-type="fig">Fig. 1B-C</xref>). H3K4me3 enriched regions mostly cluster around the TSS and relate to GO biological processes involved in ‘<italic>nucleosome assembly’</italic> and ‘<italic>protein folding</italic>’ (<xref rid="fig1" ref-type="fig">Fig. 1D</xref>). Consistent with the podocyte specific signature, the GO-term ‘Absent podocyte slit diaphragm’ featured in the <italic>Mouse Phenotype</italic> category (Suppl. Table 1 worksheet 2; FDR q-value= 0.000119119.) Indeed, close inspection of the methylation pattern around podocyte-specific genes confirmed strong H3K4me3 peaks at TSS, enrichment of H3K4me1 throughout out the gene body and depletion of the H3K27me3 repressive mark as exemplified by <italic>Wt1, Nphs1, Nphs2</italic> and <italic>Tdrd5</italic> (<xref rid="fig1" ref-type="fig">Fig. 1F-G</xref>; <xref rid="figs1" ref-type="fig">Suppl. Figure 1A</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1:</label>
<caption><title>The genome wide histone methylation patterns in adult mouse podocytes.</title>
<p>A) Schematic illustration of the podocyte isolation procedure. B) Heatmap across a set of 462 podocyte specific genes (Suppl. Table 4) <sup><xref ref-type="bibr" rid="c39">39</xref></sup> sorted according to gene size. H3K4me3 enrichment was found at the TSS, gene bodies were enriched for H3K4me1 and depleted for H3K27me3. C) Overlay of peaks at the TSS of podocyte specific genes confirmed a strong enrichment of H3K4me3 at the TSS. D) GREAT analysis for H3K4me3 peaks identified peak enrichment at TSS and enriched GO biological processes related to ‘<italic>nucleosome assembly’</italic> and ‘<italic>protein folding</italic>’. E) H3K27me3 peaks are spread further upstream and downstream of the TSS and showed a strong GO term enrichment for ‘<italic>transcription factors’</italic> and ‘d<italic>evelopmental abnormalities</italic>’. F-H) Examples of methylation tracks across the podocyte specific genes <italic>Wt1</italic> (F), <italic>Nphs2</italic> (G) and the mesoderm regulator <italic>Brachyury</italic> (H).</p></caption>
<graphic xlink:href="555670v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>By contrast H3K27me3 peaks were broader, and GREAT analysis identified GO biological terms that relate to embryonic development and differentiation processes (<xref rid="fig1" ref-type="fig">Fig. 1E</xref>). Examples included the early mesoderm marker T (Brachyury) (<xref rid="fig1" ref-type="fig">Fig. 1H</xref>), the paraxial mesoderm markers <italic>paraxis</italic> (<xref rid="figs1" ref-type="fig">Suppl. Figure 1C</xref>), the lateral plate markers <italic>Gata4</italic> (<xref rid="figs1" ref-type="fig">Suppl. Figure 1D</xref>), the gonadal marker <italic>Dmrt1</italic> (<xref rid="figs1" ref-type="fig">Suppl. Figure 1E</xref>), and the kidney progenitor marker <italic>Six2</italic> (<xref rid="figs1" ref-type="fig">Suppl. Figure 1F</xref>). This H3K27me3 methylation pattern is consistent with an active suppression of genes that orchestrate development into alternative developmental linages or genes that are expressed in early stages of kidney progenitors (such as <italic>Six2</italic>), but that are switched off during terminal differentiation. Interestingly, <italic>Hox</italic> gene clusters were split with the <italic>Hoxc10/11/12</italic> paralogues being actively repressed, whereas downstream <italic>Hox</italic> genes (<italic>Hoxd9</italic>-<italic>Hoxd1</italic>) were devoid of H3K27me3 marks (<xref rid="figs1" ref-type="fig">Suppl. Figure 1G</xref>), which is in agreement with their expression in adult podocytes <sup><xref ref-type="bibr" rid="c40">40</xref></sup>. Taken together this data set provides a blueprint of the methylation status of podocytes under homeostatic conditions.</p>
</sec>
<sec id="s3b">
<title>Identification of direct MAFB targets in adult podocytes</title>
<p>To gain further insights into podocyte-specific gene regulation, we performed ChIP-Seq analysis for the transcription factors WT1 and MAFB on isolated glomeruli of adult mice (GEO GSE233910). Consistent with published data <sup><xref ref-type="bibr" rid="c13">13</xref>,<xref ref-type="bibr" rid="c41">41</xref></sup>, WT1 bound a large number of genomic regions (17097 peaks; IDR &lt;0.01) mapping not only close to genes, but also to intergenic regions, which is in agreement with the somewhat non-classical action of WT1 (<xref rid="figs2" ref-type="fig">Suppl. Figure 2B</xref>). Comparison of our data with previously published findings <sup><xref ref-type="bibr" rid="c13">13</xref></sup> confirmed the WT1-binding motif (<xref rid="figs2" ref-type="fig">Suppl. Figure 2C</xref>) and an overlap of 87% of previously identified peaks (14946 peaks out of 17098 total peaks, data summarized in Suppl. Fig. 2D). As expected, GREAT analysis of the 17097 peaks showed an enrichment of podocyte-related GO terms (<xref rid="figs2" ref-type="fig">Suppl. Figure 2E-F</xref>).</p>
<p>Bioinformatic analysis of MAFB ChIP-Seq data from adult glomeruli identified 347 consistent peaks (IDR&lt;0.05). MEME analysis (<ext-link ext-link-type="uri" xlink:href="http://meme-suite.org">http://meme-suite.org</ext-link>) confirmed the presence of the MAFB core binding sequence that has been previously identified <italic>in silico</italic> (jaspar.genereg.net) (<xref rid="fig2" ref-type="fig">Fig. 2A</xref>). The analysis revealed a high recurrence of palindromic MAFB sites, a finding that is consistent with binding of this transcriptional regulator as a homodimer <sup><xref ref-type="bibr" rid="c42">42</xref></sup>. 57% of MAFB binding sites were found within 3kb of the transcriptions start sites (<xref rid="fig2" ref-type="fig">Fig. 2B</xref>). GREAT analysis of peak-associated genes showed GO term enrichment for cell matrix adhesion (q-value=0.004) and the cellular components of the podosome (q-value=0.01). In the mouse phenotype category, the most enriched GO terms related to abnormal podocyte physiology, including abnormal/expanded mesangial matrix morphology (q-value=0.0125 and q-value=0.0107), podocyte foot process effacement (q-value= 0.0161) and abnormal slit junction morphology (q-value=0.0164) (<xref rid="fig2" ref-type="fig">Fig. 2C</xref> and Suppl. Table 2, Worksheet2). Comparison of the list of genes associated with MAFB binding peaks with a list of 462 podocyte specific genes<sup><xref ref-type="bibr" rid="c39">39</xref></sup> showed that MAFB binds to 42 genes (Suppl. Table 2; worksheet2).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2:</label>
<caption><title>MAFB ChIP-Seq analysis.</title>
<p>A) MEME analysis of the peak centred enriched regions reveals MAFB monomeric and dimeric binding sequences. B) MAFB binding site distribution shows strong enrichment at promoter regions. C) GREAT analysis reveals binding at genes involved in cell-matrix adhesion and podocytes pathological processes. D-E) MAFB (orange), WT1 (violet) and H3K4me3 (green) tracks across the podocyte specific genes <italic>Nphs1</italic> and <italic>Nphs2</italic> and the conservation of binding sites in the mouse and human genome.</p></caption>
<graphic xlink:href="555670v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Genome wide comparison between WT1 and MAFB IDR peaks revealed 256 chromosomal regions that were bound by both transcription factors (<xref rid="fig2" ref-type="fig">Fig. 2D-E</xref> and Suppl. Table 2 worksheet 5). Closer inspection of these showed no precise spacing between the TF binding sites, which may suggest that the two TFs bind to podocyte specific genes in an independent manner. Consistent with this hypothesis, pull-down experiment in co-transfection experiments (HEK293 cells) did not show direct interaction between WT1 and MAFB (data not shown).</p>
</sec>
<sec id="s3c">
<title>MAFB is required to maintain adult podocytes fully differentiated</title>
<p>A recent study has shown that MAFB is not only important during development, but also for podocyte maintenance in adult animals<sup><xref ref-type="bibr" rid="c19">19</xref></sup>. To obtain further insights into the molecular mechanisms driven by MAFB, we employed a tamoxifen inducible <italic>Wt1-CreERT2</italic> driver<sup><xref ref-type="bibr" rid="c30">30</xref></sup> (<italic>Mafb<sup>flox/flox</sup>; Wt1-CreERT</italic> from now on called <italic>Mafb<sup>cko</sup></italic>). Despite very efficient deletion of <italic>Mafb</italic> as early as 2 days after tamoxifen injection (<xref rid="fig3" ref-type="fig">Fig. 3A</xref>&amp;B), loss of kidney function was slow, developing into overt proteinuria only 8 weeks after induction (<xref rid="fig3" ref-type="fig">Fig. 3C</xref>). Scanning and transmission electron microscopy showed a diffuse fusion of podocyte foot processes and thickening of the basement membrane (<xref rid="fig3" ref-type="fig">Fig. 3D</xref> I to IV). Histological analysis confirmed focal segmental glomerulosclerosis with excessive deposition of collagen matrix (<xref rid="fig3" ref-type="fig">Fig. 3D</xref> V and VI). Interestingly, qPCR analysis revealed only a mild reduction of podocyte specific genes even 30 days after deletion (e.g. <italic>THSD7a</italic>, <italic>Synpo, Podxl, Nphs2;</italic> <xref rid="fig3" ref-type="fig">Fig. 3F</xref>).</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3:</label>
<caption><title>Phenotypic analysis in conditional <italic>Mafb</italic> knockout mice reveals progressive kidney disease with podocyte effacement.</title>
<p>A) Strategy for the conditional knockout in <italic>Mafb<sup>cko</sup> (Wt1<sup>CreERT</sup></italic>; <italic>Mafb<sup>flox/flox</sup>; mTmG</italic>) mice. B) Confirmation of efficient loss of MAFB protein at 72h after induction (note that non-nuclear staining with the MAFB antibody is background) (scale bar: 50µm). C) Electrophoresis of urine samples showed proteinuria at 8 weeks after induction, accompanied by (D) abnormal footprocesses (SEM, I-II), thickening of the basement membrane (TEM, III-IV) and segmental sclerosis (Sirius RED, V-VI). E) Quantification of foot processes and basement membrane thickness. (n= 3 animals per condition, 20 images per animal, **** p&lt;0.001). F) Expression levels of different podocytes specific genes 3 and 30 days after TAM induction. (n=5, **** p&lt;0.001). Abbreviations: SEM=scanning electron microscope; TEM=Transmission electron microscope. GBM=glomerular basement membrane.</p></caption>
<graphic xlink:href="555670v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To obtain an unbiased view of genes that directly depend on MAFB in adult podocytes, we next performed RNA-Seq analysis (GEO GSE233912) on glomeruli isolated two days after tamoxifen induction, a time point when the expression of <italic>MafB</italic> was lost (<xref rid="fig3" ref-type="fig">Fig. 3B</xref>), <italic>Nphs2</italic> (a known target of MAFB) was reduced (<xref rid="figs3" ref-type="fig">Suppl. Figure 3A</xref>), but no overt phenotypic abnormalities were present. Pearson and PCA analysis confirmed clustering of wildtype and knockout samples into two different groups (<xref rid="figs3" ref-type="fig">Suppl. Figure 3B&amp;C</xref>). Differential expression analysis identified 1109 (693) and 1178 (724) genes to be decreased and increased in <italic>Mafb<sup>cko</sup></italic> animals at an adjusted p-Value of p<sub>adj</sub> &lt;0.05 (p<sub>adj</sub> &lt;0.01), respectively (<xref rid="fig4" ref-type="fig">Fig. 4A</xref> and Suppl. Table 3). <italic>Enrichr</italic> analysis of downregulated genes identified GO-terms including ‘<italic>Genes controlling nephrogenesis’</italic> (p=1.6×10<sup>-6</sup>), nephrotic syndrome (p=2.0×10<sup>-5</sup>) and ‘<italic>VEGFA-VEGFR2 signaling’</italic> (p=2.0×10<sup>-5</sup>) (<xref rid="fig4" ref-type="fig">Fig. 4B</xref>). GO- terms for upregulated genes included ‘<italic>Tgf-β regulation of extracellular matrix’</italic> (p=9×10<sup>-6</sup>), ‘<italic>nephrin interactions’</italic> (p=1×10<sup>-4</sup>) and ‘<italic>Rac1/Rho1 motility signaling pathways’</italic> (p=1×10<sup>-3</sup>) (<xref rid="fig4" ref-type="fig">Fig. 4C</xref>), which probably reflects the cellular response of the podocyte to the reduction of key components of the slit diaphragm such as <italic>Nphs1</italic> and <italic>Nphs2</italic>. GSEA analysis with a list of podocyte-specific differentiation markers <sup><xref ref-type="bibr" rid="c40">40</xref></sup> showed a significant loss of podocyte specific genes (<xref rid="fig4" ref-type="fig">Fig. 4D</xref>; enrichment score = 0.65) and a return to a precursor phenotype (<xref rid="fig4" ref-type="fig">Fig. 4E</xref>; enrichment score=-0.4).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4:</label>
<caption><title>RNAseq analysis in <italic>Mafb<sup>cko</sup></italic> podocytes.</title><p>A) Heat map of deregulated genes three days after tamoxifen induction. B) <italic>Enrichr</italic> analysis of 693 downregulated genes (p<sub>adj</sub>&lt;0.01) reveals GO-term enrichment for ‘<italic>podocyte dysfunction</italic>’ and ‘<italic>VEGFA/VEGFR2 signalling’.</italic> C) Go Term enrichment analysis for upregulated genes highlighted ‘<italic>Tgfb regulation of extracellular matrix’</italic> and ‘<italic>Nephrin interactions’</italic>. D-E) GSEA analysis of the deregulated genes indicate a rapid reversion of podocytes to a more undifferentiated state after <italic>Mafb</italic> inactivation. F) Venn diagram and G) gene list of the intersections between the different datasets (<italic>Mafb<sup>cko</sup></italic> upregulated genes, <italic>Mafb<sup>cko</sup></italic> downregulated genes, MAFB ChIP peaks, Podocyte specific genes) identified direct and indirect MAFB targets. H) GSEA analysis of the RNA-seq data highlighted ‘<italic>TCF21/POD1 targets’</italic> to be affected in <italic>Mafb<sup>cko</sup></italic> animals. I) ChIP- Seq tracks reveal peaks for MAFB and WT1 approximately 49.5kb upstream of the <italic>Tcf21</italic> promoter. J) Inspection of the corresponding chromosomal region reveals a high degree of evolutionary conservation.</p></caption>
<graphic xlink:href="555670v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Comparison of significantly deregulated transcripts with genes that map close to MAFB ChIP-Seq peaks indicates 64 genes to be directly regulated by this transcription factor, 11 of which appeared to be podocyte specific (<xref rid="fig4" ref-type="fig">Fig. 4</xref> F&amp;G). The much higher number of significantly downregulated genes in absence of MAFB (p&lt;0.01, n=693) compared to the relatively low number of direct targets detected by ChIP-Seq may suggest secondary effects already at this early stage after deletion. Interestingly, we found <italic>Pod1/Tcf21</italic>, a gene with important functions in glomerular development <sup><xref ref-type="bibr" rid="c8">8</xref>–<xref ref-type="bibr" rid="c11">11</xref></sup>, to be reduced upon <italic>MafB</italic> deletion (p<sub>adj</sub>=2.0×10<sup>-7</sup>; 1.8fold; Suppl. Table 3). Furthermore, GSEA analysis revealed ‘<italic>Tcf21 targets’</italic> as a key GO-term enriched in control over knockout samples (enrichment score 0.6; <xref rid="fig4" ref-type="fig">Fig. 4H</xref>). Examination of the genomic locus revealed peaks for MAFB and WT1 48.5kb upstream of the <italic>Tcf21</italic> transcription start site (<xref rid="fig4" ref-type="fig">Fig. 4I</xref>&amp;J), a region that is evolutionary conserved in placental animals and has been identified as a candidate cis-regulatory region (Encode project). We conclude that MAFB achieves its podocyte-specific function by directly regulating a subset of podocyte specific genes including other transcription factors required for terminal differentiation, such as <italic>Tcf21</italic>.</p>
</sec>
<sec id="s3d">
<title>MAFB is required for chromatin accessibility of podocyte specific promoters</title>
<p>To gain further insights into the molecular mechanisms underlying podocyte differentiation we turned our attention to development. Comparison of the expression pattern on mouse tissues revealed that MAFB expression occurs after WT1, but slightly before NPHS1 and NPHS2 (<xref rid="figs4" ref-type="fig">Suppl. Figure 4A</xref>). Analysis of a publicly available single cell database (<ext-link ext-link-type="uri" xlink:href="https://cellxgene.cziscience.com/e/08073b32-d389-41f4-a4fd-616de76915ab.cxg/">https://cellxgene.cziscience.com/e/08073b32-d389-41f4-a4fd-616de76915ab.cxg/</ext-link>) <sup><xref ref-type="bibr" rid="c37">37</xref></sup> confirmed a similar expression profile in human nephron development (<xref rid="figs4" ref-type="fig">Suppl. Figure 4B</xref>). Mice homozygous for the <italic>Mafb<sup>GFP</sup></italic> knock-in that represents a loss-of-function allele completely lacked NPHS1 and NPHS2 despite the persistence of WT1 expression (<xref rid="fig5" ref-type="fig">Fig. 5A</xref>). We therefore hypothesized that MAFB may be involved in chromatin opening thus allowing other transcription factors such as WT1 to access promoter regions of podocyte specific genes. To test this model, we carried out ChIP experiments with antibodies against the active chromatin mark H3K4me3 on E17.5 wildtype and <italic>Mafb<sup>Gfp/Gfp</sup></italic> kidneys. As expected, <italic>Nphs1</italic>, <italic>Nphs2</italic>, <italic>Synpo</italic> promoter regions were enriched for H3K4me3 modification implying an open chromatin structure in wildtype samples (<xref rid="fig5" ref-type="fig">Fig. 5B</xref>). Regions downstream of these genes were not enriched and served as negative controls. By contrast, in <italic>Mafb<sup>Gfp/Gfp</sup></italic> samples chromatin at the <italic>Nphs1</italic> and <italic>Nphs2</italic> promoter failed to be precipitated with H3K4me3 antibodies. Of note, the <italic>Synpo</italic> promoter remained open as demonstrated by maintenance of the enrichment and the residual expression level observed in the IF. To test if changes in the methylation pattern would directly impact binding of other podocyte specific transcription factors, we evaluated the binding of WT1 to these regions. Strikingly, WT1 enrichment was completely lost at <italic>Nphs1/Nphs2</italic> promoters, but only slightly reduced at the regulatory region of <italic>Synpo</italic> (<xref rid="fig5" ref-type="fig">Fig. 5B</xref>), a gene that is not bound by MAFB (Suppl. Table 2, Worksheet 1). We conclude that MAFB is crucial to permit chromatin accessibility at its targets, thus allowing transcription factors, such as WT1, to bind and activate key genes of the podocyte.</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5:</label>
<caption><title>ChIP-qPCR analysis of chromatin conformation in <italic>Mafb</italic> KO embryonic kidney.</title><p><bold>A)</bold> Immuno-florescence analysis in E18.5 homozygous <italic>Mafb</italic> knockout animals (<italic>Mafb<sup>GFP/GFP</sup></italic>) shows complete loss of the direct targets NPHS1 and NPHS2, whereas WT1 and synaptopodin (SYNPO) remain expressed (scale bar: 100µm). B) qPCR analysis of replicated immunoprecipitated chromatin with WT1 (yellow bars) and H3K4me3 (green bars) antibodies in E18.5 embryonic kidneys reveals loss of histone methylation and WT1 binding at <italic>Nphs1</italic> and <italic>Nphs2</italic> promoters. C) Schematic illustration of the role of MAFB in podocyte development. <italic>Mafb</italic> is a target of WT1, but is also required to permit access of WT1 to other podocyte-specific genes.</p></caption>
<graphic xlink:href="555670v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>The transcriptional profile of a cell is shaped by the epigenetic landscape that permits or interferes with binding of TFs and thus the activation of cell type specific genes. In this study we determined the map of histone marks in the adult podocyte, which provides important insights into specific gene regulation and will serve as a resource for future analysis. Not surprisingly, strong H3K4me3 peaks were found at transcription start sites of a large number of genes, with podocyte specific genes often showing very broad peaks. H3K4me3 peak breadth has been shown previously to be highly dynamic and directly associated with transcriptional activity <sup><xref ref-type="bibr" rid="c43">43</xref></sup>. In contrast to H3K4me3 modifications, the repressive H3K27me3 mark was predominantly found covering developmental genes. In particular, genes encoding transcription factors that are active at an earlier time point (e.gi. <italic>T, Gata4, Six2</italic>) were covered with repressive marks. This is consistent with the known role of the PRC2 complex that actively represses genes to lock in developmental decisions <sup><xref ref-type="bibr" rid="c44">44</xref></sup>. Hox genes are peculiar as they show collinearity of gene expression during early stages of development and progressive silencing of members within a cluster is accompanied by histone methylation via the PRC complex <sup><xref ref-type="bibr" rid="c45">45</xref></sup>. In podocytes, H3K27me3 methylation followed this pattern with only the silent portion of each cluster being CpG-marked.</p>
<p>Active suppression by H3K27me3 is important as podocyte specific deletion of <italic>Ezh2</italic>, a crucial member of the PRC2 complex, sensitizes mice to glomerular disease<sup><xref ref-type="bibr" rid="c46">46</xref></sup>. On the molecular level this has been suggested to be due to an increase of Notch signalling and in particular a loss of <italic>Jag1</italic> H3K27me3 methylation. In our data we did not find strong H3K27me3 methylation at the <italic>Jag1</italic> locus, which may suggest that demethylation at this locus is not a primary cause of dysfunction in <italic>Ezh2</italic> mutant podocytes. In the future it will be interesting to investigate in detail epigenetic changes on a genome wide scale in glomerular diseases and link them with the observed changes in gene expression.</p>
<p>We also describe the genome wide binding sites of MAFB in podocytes <italic>in vivo</italic>. Compared to WT1, which shows very promiscuous binding (17098 peaks), the number of MAFB peaks with an IDR &lt;0.05 was relatively low (349 peaks), suggesting a more selective target site selection. This is consistent with a recent study that showed enrichment for WT1 and FOXC2, but not MAFB in glomeruli specific super-enhancers<sup><xref ref-type="bibr" rid="c3">3</xref></sup>. Previous studies in other organ systems have identified a larger number of MAFB targets, which may be due to a less stringent IDR analysis in their studies <sup><xref ref-type="bibr" rid="c47">47</xref>,<xref ref-type="bibr" rid="c48">48</xref></sup>. The binding motif detected precisely fits the expected MAFB recognition sequence, with a large proportion of sites showing palindromic sites indicating binding as a homodimer. 256 of the identified MAFB regions (including <italic>Nphs1</italic> and <italic>Nphs2</italic> promoters) appear to be also bound by WT1, which may suggest that these two transcription factors cooperate in the activation of downstream targets. The absence of a precise spacing between the binding sites and the lack of co-precipitation after co-transfection into HEK293 cells suggests this cooperation not to involve physical interaction. Instead we propose that MAFB is required to allow WT1 factors to access chromatin and thus permit activation of a subset of podocyte specific genes (<xref rid="fig5" ref-type="fig">Fig. 5C</xref>).</p>
<p>While this study was in progress, a manuscript reported that deletion of MAFB with the <italic>Nphs2-CreERT2</italic> driver in adult podocytes leads to glomerular defects 8 weeks after induction<sup><xref ref-type="bibr" rid="c19">19</xref></sup>. Our own data using a different Cre driver (<italic>Wt1-CreERT2</italic>) that induces &gt;95% deletion of <italic>Mafb</italic> at protein level three days after induction confirms this relatively slow, but progressive kidney disease. In contrast to the previously published study that reported transcriptomic analysis at a rather late time point (8 weeks after induction), our RNA-Seq analysis was performed only two days after tamoxifen induction, which allowed us to look at primary events. Despite the rapid loss of MAFB protein after inactivation, we observed only a relatively mild reduction of a broad spectrum of genes, including podocyte marker proteins. The intersection of RNA- seq and ChIPseq data allowed us to elaborate a transcriptional cascade. Indeed, <italic>Lmx1b</italic> and <italic>TCF21/Pod1</italic>, are directly regulated by MAFB, whereas the key regulator <italic>WT1</italic> remains normally expressed in absence of MAFB. MAFB can therefore be considered in an intermediate hierarchic position, downstream of WT1 (by which it is activated), but responsible for high <italic>TCF21/Pod1</italic> and <italic>Lmx1b</italic> expression levels and, as a consequence, their downstream effector genes. Contrary to published <italic>in vitro</italic> experiments<sup><xref ref-type="bibr" rid="c19">19</xref></sup>, we did not find significant enrichment at the <italic>Tcf21</italic> start site in <italic>our in vivo</italic> ChIP-Seq experiments. Instead we identified an evolutionary conserved element 49.5kb upstream of <italic>Tcf21</italic> that is bound by both WT1 and MAFB and has been identified as a potential cis-regulatory element by the ENCODE project. Given the important function of TCF21 in podocyte differentiation, it will be interesting to test this region for mutations in patients with unexplained cases of glomerulopathies.</p>
<p>In contrast to the relatively mild kidney phenotype after tamoxifen induced deletion of <italic>Mafb</italic> in adults, constitutive deletion abolishes terminal podocyte differentiation. Our data point to a crucial role for MAFB as a pioneer transcription factor that allows chromatin to open and other factors to bind <sup><xref ref-type="bibr" rid="c49">49</xref></sup>. Expression of MAFB has been shown in the epidermis to be both necessary and sufficient to exit cell cycle and promote progenitor differentiation <sup><xref ref-type="bibr" rid="c50">50</xref></sup>. Once chromatin has been opened, MAFB may no longer be essential to permit continuous transcription of podocyte specific genes. This model is supported by our ChIP studies in developmental kidneys which demonstrate that loss of MAFB leads to a lack of open chromatin and strongly reduced binding of WT1 at the <italic>Nphs1</italic> and <italic>Nphs2</italic> loci.</p>
<p>Taken together our study describes the epigenetic landscape of mouse podocytes, identified genome wide binding sites for MAFB and discovered an important role of MAFB during differentiation in opening chromatin and other TFs expression and binding to promoters of podocyte specific genes.</p>
</sec>
<sec id="d1e1243" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="d1e1352">
<label>Supplementary Table 1</label>
<media xlink:href="supplements/555670_file02.pdf"/>
</supplementary-material>
<supplementary-material id="d1e1359">
<label>Supplementary Table 2</label>
<media xlink:href="supplements/555670_file03.pdf"/>
</supplementary-material>
<supplementary-material id="d1e1366">
<label>Supplementary Table 3</label>
<media xlink:href="supplements/555670_file04.pdf"/>
</supplementary-material>
<supplementary-material id="d1e1373">
<label>Supplementary Table 4</label>
<media xlink:href="supplements/555670_file05.pdf"/>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We would like to thank the entire staff of the iBV animal facility for their dedication. We are grateful to William Pu for providing us with the <italic>Wt1<sup>CreERT</sup></italic><sup><xref ref-type="bibr" rid="c2">2</xref></sup> strain. This study was supported by institutional grants from TU Dresden, the Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, University Cote d’Azur and Aix-Marseille University and grants to A.S. from the Fondation pour la Recherche Médicale (ING20160435020), ANR (ANR-12-BSV 1-0033-02; ANR-11-LABX-0028-01), the European Commission (EURenOmics Grant agreement 305608), Conseil Régional Sud Est PACA”, the “Conseil Départemental 06”, to M.H. Sieweke from Fondation pour la Recherche Médicale (DEQ. 20110421320), the ‘Agence Nationale de la Recherche’ (ANR-11-BSV3-026-01, ANR-17-CE15-0007-01 and ANR-18-CE12-0019-03), INCA (13-10/405/AB-LC-HS), Fondation ARC pour la Recherche sur le Cancer (PGA1 RF20170205515), an INSERM-Helmholtz cooperation and the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement number 695093 MacAge). M.H. Sieweke is an Alexander von Humboldt Professor at TU Dresden. The authors acknowledge the University’s CCMA, Electron Microscopy facility (Centre Commun de Microscopie Appliquée, Université Côte d’Azur) and MICA Imaging platform Côte d’Azur supported by Université Côte d’Azur, the “Conseil Régional Sud Est PACA”, the “Conseil Départemental 06 “ and Gis Ibisa, and Christelle Boscagli for her technical help.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Jambhekar</surname> <given-names>A</given-names></string-name>, <string-name><surname>Dhall</surname> <given-names>A</given-names></string-name>, <string-name><surname>Shi</surname> <given-names>Y</given-names></string-name><article-title>: Roles and regulation of histone methylation in animal development [Internet]</article-title>. <source>Nat. Rev. Mol. Cell Biol</source>. <volume>20</volume>: <fpage>625</fpage>–<lpage>641</lpage>, <year>2019</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed-ncbi-nlm-nih-gov.proxy.insermbiblio.inist.fr/31267065/">https://pubmed-ncbi-nlm-nih-gov.proxy.insermbiblio.inist.fr/31267065/</ext-link> [cited 2021 May 11]</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>O’Carroll</surname> <given-names>D</given-names></string-name>, <string-name><surname>Erhardt</surname> <given-names>S</given-names></string-name>, <string-name><surname>Pagani</surname> <given-names>M</given-names></string-name>, <string-name><surname>Barton</surname> <given-names>SC</given-names></string-name>, <string-name><surname>Surani</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Jenuwein</surname> <given-names>T</given-names></string-name><article-title>: The Polycomb -Group Gene Ezh2 Is Required for Early Mouse Development</article-title>. <source>Mol. Cell. Biol. [Internet</source>] <volume>21</volume>: <fpage>4330</fpage>–<lpage>4336</lpage>, <year>2001</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://journals.asm.org/doi/10.1128/MCB.21.13.4330-4336.2001">https://journals.asm.org/doi/10.1128/MCB.21.13.4330-4336.2001</ext-link> [cited 2022 Dec 2]</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Motojima</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kume</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hou</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Pan</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Duan</surname> <given-names>A</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hou</surname> <given-names>J</given-names></string-name>, <string-name><surname>Shi</surname> <given-names>J</given-names></string-name>, <string-name><surname>Qin</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Z</given-names></string-name><article-title>: Super-Enhancer-Associated Transcription Factors Maintain Transcriptional Regulation in Mature Podocytes</article-title>. <source>J. Am. Soc. Nephrol. [Internet] ASN</source>.<volume>2020081177</volume>, <year>2021</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771836/">https://pubmed.ncbi.nlm.nih.gov/33771836/</ext-link> [cited 2021 May 11]</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>He</surname> <given-names>B</given-names></string-name>, <string-name><surname>Ebarasi</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Guo</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ojala</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Hultenby</surname> <given-names>K</given-names></string-name>, <string-name><surname>De Val</surname> <given-names>S</given-names></string-name>, <string-name><surname>Betsholtz</surname> <given-names>C</given-names></string-name>, <string-name><surname>Tryggvason</surname> <given-names>K</given-names></string-name><article-title>: Lmx1b and FoxC combinatorially regulate podocin expression in podocytes</article-title>. <source>J Am Soc Nephrol [Internet</source>] <volume>25</volume>: <fpage>2764</fpage>– <lpage>2777</lpage>, <year>2014</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/24854274">https://www.ncbi.nlm.nih.gov/pubmed/24854274</ext-link></mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>O’Brien</surname> <given-names>LL</given-names></string-name>, <string-name><surname>Grimaldi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kostun</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Wingert</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Selleck</surname> <given-names>R</given-names></string-name>, <string-name><surname>Davidson</surname> <given-names>AJ</given-names></string-name><article-title>: Wt1a, Foxc1a, and the Notch mediator Rbpj physically interact and regulate the formation of podocytes in zebrafish</article-title>. <source>Dev Biol</source> [Internet] <volume>358</volume>: <fpage>318</fpage>–<lpage>330</lpage>, <year>2011</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21871448">http://www.ncbi.nlm.nih.gov/pubmed/21871448</ext-link></mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>White</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>B</given-names></string-name>, <string-name><surname>Cerqueira</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Tran</surname> <given-names>U</given-names></string-name>, <string-name><surname>Wessely</surname> <given-names>O</given-names></string-name>: <article-title>Notch signaling, wt1 and foxc2 are key regulators of the podocyte gene regulatory network in Xenopus</article-title>. <source>Development</source> [Internet] <volume>137</volume>: <fpage>1863</fpage>–<lpage>1873</lpage>, <year>2010</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/20431116">https://www.ncbi.nlm.nih.gov/pubmed/20431116</ext-link></mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Motojima</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kume</surname> <given-names>T</given-names></string-name>, <string-name><surname>Matsusaka</surname> <given-names>T</given-names></string-name><article-title>: Foxc1 and Foxc2 are necessary to maintain glomerular podocytes</article-title>. <source>Exp. Cell Res</source>. <volume>352</volume>: <fpage>265</fpage>–<lpage>272</lpage>, <year>2017</year></mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Morello</surname> <given-names>R</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>G</given-names></string-name>, <string-name><surname>Dreyer</surname> <given-names>SD</given-names></string-name>, <string-name><surname>Harvey</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Ninomiya</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Thorner</surname> <given-names>PS</given-names></string-name>, <string-name><surname>Miner</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Cole</surname> <given-names>W</given-names></string-name>, <string-name><surname>Winterpacht</surname> <given-names>A</given-names></string-name>, <string-name><surname>Zabel</surname> <given-names>B</given-names></string-name>, <string-name><surname>Oberg</surname> <given-names>KC</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>B</given-names></string-name><article-title>: Regulation of glomerular basement membrane collagen expression by LMX1B contributes to renal disease in nail patella syndrome</article-title>. <source>Nat Genet [Internet</source>] <volume>27</volume>: <fpage>205</fpage>–<lpage>208</lpage>, <year>2001</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/11175791">https://www.ncbi.nlm.nih.gov/pubmed/11175791</ext-link></mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Rohr</surname> <given-names>C</given-names></string-name>, <string-name><surname>Prestel</surname> <given-names>J</given-names></string-name>, <string-name><surname>Heidet</surname> <given-names>L</given-names></string-name>, <string-name><surname>Hosser</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kriz</surname> <given-names>W</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Antignac</surname> <given-names>C</given-names></string-name>, <string-name><surname>Witzgall</surname> <given-names>R</given-names></string-name><article-title>: The LIM-homeodomain transcription factor Lmx1b plays a crucial role in podocytes</article-title>. <source>J. Clin. Invest</source>. <volume>109</volume>: <fpage>1073</fpage>–<lpage>1082</lpage>, <year>2002</year></mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Miner</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Morello</surname> <given-names>R</given-names></string-name>, <string-name><surname>Andrews</surname> <given-names>KL</given-names></string-name>, <string-name><surname>Li</surname> <given-names>C</given-names></string-name>, <string-name><surname>Antignac</surname> <given-names>C</given-names></string-name>, <string-name><surname>Shaw</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>B</given-names></string-name><article-title>: Transcriptional induction of slit diaphragm genes by Lmx1b is required in podocyte differentiation</article-title>. <source>J. Clin. Invest. [Internet</source>] <volume>109</volume>: <fpage>1065</fpage>– <lpage>1072</lpage>, <year>2002</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11956244/">https://pubmed.ncbi.nlm.nih.gov/11956244/</ext-link> [cited 2021 May 11]</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Maezawa</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Onay</surname> <given-names>T</given-names></string-name>, <string-name><surname>Scott</surname> <given-names>RP</given-names></string-name>, <string-name><surname>Keir</surname> <given-names>LS</given-names></string-name>, <string-name><surname>Dimke</surname> <given-names>H</given-names></string-name>, <string-name><surname>Li</surname> <given-names>C</given-names></string-name>, <string-name><surname>Eremina</surname> <given-names>V</given-names></string-name>, <string-name><surname>Maezawa</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Jeansson</surname> <given-names>M</given-names></string-name>, <string-name><surname>Shan</surname> <given-names>J</given-names></string-name>, <string-name><surname>Binnie</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lewin</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ghosh</surname> <given-names>A</given-names></string-name>, <string-name><surname>Miner</surname> <given-names>JH</given-names></string-name>, <string-name><surname>Vainio</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Quaggin</surname> <given-names>SE</given-names></string-name><article-title>: Loss of the podocyte-expressed transcription factor Tcf21/Pod1 Results in podocyte differentiation defects and FSGS</article-title>. <source>J. Am. Soc. Nephrol</source>. <volume>25</volume>: <fpage>2459</fpage>– <lpage>2470</lpage>, <year>2014</year></mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Lefebvre</surname> <given-names>J</given-names></string-name>, <string-name><surname>Clarkson</surname> <given-names>M</given-names></string-name>, <string-name><surname>Massa</surname> <given-names>F</given-names></string-name>, <string-name><surname>Bradford</surname> <given-names>ST</given-names></string-name>, <string-name><surname>Charlet</surname> <given-names>A</given-names></string-name>, <string-name><surname>Buske</surname> <given-names>F</given-names></string-name>, <string-name><surname>Lacas-Gervais</surname> <given-names>S</given-names></string-name>, <string-name><surname>Schulz</surname> <given-names>H</given-names></string-name>, <string-name><surname>Gimpel</surname> <given-names>C</given-names></string-name>, <string-name><surname>Hata</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Schaefer</surname> <given-names>F</given-names></string-name>, <string-name><surname>Schedl</surname> <given-names>A</given-names></string-name><article-title>: Alternatively spliced isoforms of WT1 control podocyte-specific gene expression</article-title>. <source>Kidney Int</source>. <year>2015</year></mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Kann</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ettou</surname> <given-names>S</given-names></string-name>, <string-name><surname>Jung</surname> <given-names>YL</given-names></string-name>, <string-name><surname>Lenz</surname> <given-names>MO</given-names></string-name>, <string-name><surname>Taglienti</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Park</surname> <given-names>PJ</given-names></string-name>, <string-name><surname>Schermer</surname> <given-names>B</given-names></string-name>, <string-name><surname>Benzing</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kreidberg</surname> <given-names>JA</given-names></string-name><article-title>: Genome-Wide Analysis of Wilms’ Tumor 1-Controlled Gene Expression in Podocytes Reveals Key Regulatory Mechanisms</article-title>. <source>J Am Soc Nephrol [Internet</source>] <year>2015</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/25636411">http://www.ncbi.nlm.nih.gov/pubmed/25636411</ext-link></mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Dong</surname> <given-names>L</given-names></string-name>, <string-name><surname>Pietsch</surname> <given-names>S</given-names></string-name>, <string-name><surname>Tan</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Perner</surname> <given-names>B</given-names></string-name>, <string-name><surname>Sierig</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kruspe</surname> <given-names>D</given-names></string-name>, <string-name><surname>Groth</surname> <given-names>M</given-names></string-name>, <string-name><surname>Witzgall</surname> <given-names>R</given-names></string-name>, <string-name><surname>Grone</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Platzer</surname> <given-names>M</given-names></string-name>, <string-name><surname>Englert</surname> <given-names>C</given-names></string-name><article-title>: Integration of Cistromic and Transcriptomic Analyses Identifies Nphs2, Mafb, and Magi2 as Wilms’ Tumor 1 Target Genes in Podocyte Differentiation and Maintenance</article-title>. <source>J Am Soc Nephrol</source> [Internet] <year>2015</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/25556170">http://www.ncbi.nlm.nih.gov/pubmed/25556170</ext-link></mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Barbaux</surname> <given-names>S</given-names></string-name>, <string-name><surname>Niaudet</surname> <given-names>P</given-names></string-name>, <string-name><surname>Gubler</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Grunfeld</surname> <given-names>JP</given-names></string-name>, <string-name><surname>Jaubert</surname> <given-names>F</given-names></string-name>, <string-name><surname>Kuttenn</surname> <given-names>F</given-names></string-name>, <string-name><surname>Fekete</surname> <given-names>CN</given-names></string-name>, <string-name><surname>Souleyreau Therville</surname> <given-names>N</given-names></string-name>, <string-name><surname>Thibaud</surname> <given-names>E</given-names></string-name>, <string-name><surname>Fellous</surname> <given-names>M</given-names></string-name>, <string-name><surname>McElreavey</surname> <given-names>K</given-names></string-name><article-title>: Donor splice-site mutations in WT1 are responsible for Frasier syndrome</article-title>. <source>Nat Genet</source> <volume>17</volume>: <fpage>467</fpage>–<lpage>470</lpage>, <year>1997</year></mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Klamt</surname> <given-names>B</given-names></string-name>, <string-name><surname>Koziell</surname> <given-names>A</given-names></string-name>, <string-name><surname>Poulat</surname> <given-names>F</given-names></string-name>, <string-name><surname>Wieacker</surname> <given-names>P</given-names></string-name>, <string-name><surname>Scambler</surname> <given-names>P</given-names></string-name>, <string-name><surname>Berta</surname> <given-names>P</given-names></string-name>, <string-name><surname>Gessler</surname> <given-names>M</given-names></string-name><article-title>: Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms</article-title>. <source>Hum Mol Genet</source>. <volume>7</volume>: <fpage>709</fpage>–<lpage>714</lpage>, <year>1998</year></mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname> <given-names>FP</given-names></string-name>, <string-name><surname>Breslow</surname> <given-names>NE</given-names></string-name>, <string-name><surname>Morgan</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Ghahremani</surname> <given-names>M</given-names></string-name>, <string-name><surname>Miller</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Grundy</surname> <given-names>PE</given-names></string-name>, <string-name><surname>Green</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Diller</surname> <given-names>LR</given-names></string-name>, <string-name><surname>Pelletier</surname> <given-names>J</given-names></string-name><article-title>: Germline WT1 mutations in Wilms’ tumor patients: preliminary results</article-title>. <source>Med.Pediatr.Oncol</source>. <volume>27</volume>: <fpage>404</fpage>– <lpage>407</lpage>, <year>1996</year></mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Pelletier</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bruening</surname> <given-names>W</given-names></string-name>, <string-name><surname>Kashtan</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Mauer</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Manivel</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Striegel</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Houghton</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Junien</surname> <given-names>C</given-names></string-name>, <string-name><surname>Habib</surname> <given-names>R</given-names></string-name>, <string-name><surname>Fouser</surname> <given-names>L</given-names></string-name>, <etal>et al</etal>: <article-title>Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome</article-title>. <source>Cell</source>. <volume>67</volume>: <fpage>437</fpage>–<lpage>447</lpage>, <year>1991</year></mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Usui</surname> <given-names>T</given-names></string-name>, <string-name><surname>Morito</surname> <given-names>N</given-names></string-name>, <string-name><surname>Shawki</surname> <given-names>HH</given-names></string-name>, <string-name><surname>Sato</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Tsukaguchi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hamada</surname> <given-names>M</given-names></string-name>, <string-name><surname>Jeon</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yadav</surname> <given-names>MK</given-names></string-name>, <string-name><surname>Kuno</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tsunakawa</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Okada</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ojima</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kanai</surname> <given-names>M</given-names></string-name>, <string-name><surname>Asano</surname> <given-names>K</given-names></string-name>, <string-name><surname>Imamura</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Koshida</surname> <given-names>R</given-names></string-name>, <string-name><surname>Yoh</surname> <given-names>K</given-names></string-name>, <string-name><surname>Usui</surname> <given-names>J</given-names></string-name>, <string-name><surname>Yokoi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kasahara</surname> <given-names>M</given-names></string-name>, <string-name><surname>Yoshimura</surname> <given-names>A</given-names></string-name>, <string-name><surname>Muratani</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kudo</surname> <given-names>T</given-names></string-name>, <string-name><surname>Oishi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yamagata</surname> <given-names>K</given-names></string-name>, <string-name><surname>Takahashi</surname> <given-names>S</given-names></string-name><article-title>: Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis</article-title>. <source>Kidney Int. [Internet</source>] <volume>98</volume>: <fpage>391</fpage>–<lpage>403</lpage>, <year>2020</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32622525/">https://pubmed.ncbi.nlm.nih.gov/32622525/</ext-link> [cited 2021 May 11]</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Moriguchi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hamada</surname> <given-names>M</given-names></string-name>, <string-name><surname>Morito</surname> <given-names>N</given-names></string-name>, <string-name><surname>Terunuma</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hasegawa</surname> <given-names>K</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Yokomizo</surname> <given-names>T</given-names></string-name>, <string-name><surname>Esaki</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kuroda</surname> <given-names>E</given-names></string-name>, <string-name><surname>Yoh</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kudo</surname> <given-names>T</given-names></string-name>, <string-name><surname>Nagata</surname> <given-names>M</given-names></string-name>, <string-name><surname>Greaves</surname> <given-names>DR</given-names></string-name>, <string-name><surname>Engel</surname> <given-names>JD</given-names></string-name>, <string-name><surname>Yamamoto</surname> <given-names>M</given-names></string-name>, <string-name><surname>Takahashi</surname> <given-names>S</given-names></string-name><article-title>: MafB is essential for renal development and F4/80 expression in macrophages</article-title>. <source>Mol Cell Biol [Internet</source>] <volume>26</volume>: <fpage>5715</fpage>–<lpage>5727</lpage>, <year>2006</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/16847325">http://www.ncbi.nlm.nih.gov/pubmed/16847325</ext-link></mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Sato</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Tsukaguchi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Morita</surname> <given-names>H</given-names></string-name>, <string-name><surname>Higasa</surname> <given-names>K</given-names></string-name>, <string-name><surname>Tran</surname> <given-names>MTN</given-names></string-name>, <string-name><surname>Hamada</surname> <given-names>M</given-names></string-name>, <string-name><surname>Usui</surname> <given-names>T</given-names></string-name>, <string-name><surname>Morito</surname> <given-names>N</given-names></string-name>, <string-name><surname>Horita</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hayashi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Takagi</surname> <given-names>J</given-names></string-name>, <string-name><surname>Yamaguchi</surname> <given-names>I</given-names></string-name>, <string-name><surname>Nguyen</surname> <given-names>HT</given-names></string-name>, <string-name><surname>Harada</surname> <given-names>M</given-names></string-name>, <string-name><surname>Inui</surname> <given-names>K</given-names></string-name>, <string-name><surname>Maruta</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Inoue</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Koiwa</surname> <given-names>F</given-names></string-name>, <string-name><surname>Sato</surname> <given-names>H</given-names></string-name>, <string-name><surname>Matsuda</surname> <given-names>F</given-names></string-name>, <string-name><surname>Ayabe</surname> <given-names>S</given-names></string-name>, <string-name><surname>Mizuno</surname> <given-names>S</given-names></string-name>, <string-name><surname>Sugiyama</surname> <given-names>F</given-names></string-name>, <string-name><surname>Takahashi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yoshimura</surname> <given-names>A</given-names></string-name><article-title>: A mutation in transcription factor MAFB causes Focal Segmental Glomerulosclerosis with Duane Retraction Syndrome</article-title>. <source>Kidney Int. [Internet</source>] <volume>94</volume>: <fpage>396</fpage>–<lpage>407</lpage>, <year>2018</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29779709/">https://pubmed.ncbi.nlm.nih.gov/29779709/</ext-link> [cited 2021 May 11]</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="web"><string-name><surname>Chau</surname> <given-names>YY</given-names></string-name>, <string-name><surname>Brownstein</surname> <given-names>D</given-names></string-name>, <string-name><surname>Mjoseng</surname> <given-names>H</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>WC</given-names></string-name>, <string-name><surname>Buza-Vidas</surname> <given-names>N</given-names></string-name>, <string-name><surname>Nerlov</surname> <given-names>C</given-names></string-name>, <string-name><surname>Jacobsen</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Perry</surname> <given-names>P</given-names></string-name>, <string-name><surname>Berry</surname> <given-names>R</given-names></string-name>, <string-name><surname>Thornburn</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sexton</surname> <given-names>D</given-names></string-name>, <string-name><surname>Morton</surname> <given-names>N</given-names></string-name>, <string-name><surname>Hohenstein</surname> <given-names>P</given-names></string-name>, <string-name><surname>Freyer</surname> <given-names>E</given-names></string-name>, <string-name><surname>Samuel</surname> <given-names>K</given-names></string-name>, <string-name><surname>Van’t Hof</surname> <given-names>R</given-names></string-name>, <string-name><surname>Hastie</surname> <given-names>N</given-names></string-name>: <article-title>Acute multiple organ failure in adult mice deleted for the developmental regulator wt1</article-title>. <source>PLoS Genet</source> [Internet] 7: e1002404, 2011 Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=22216009">http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=22216009</ext-link></mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Wagner</surname> <given-names>N</given-names></string-name>, <string-name><surname>Wagner</surname> <given-names>KD</given-names></string-name>, <string-name><surname>Xing</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Scholz</surname> <given-names>H</given-names></string-name>, <article-title>Schedl A: The major podocyte protein nephrin is transcriptionally activated by the Wilms’ tumor suppressor WT1</article-title>. <source>J. Am. Soc. Nephrol</source>. [Internet] <volume>15</volume>: <fpage>3044</fpage>–<lpage>3051</lpage>, <year>2004</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15579507/">https://pubmed.ncbi.nlm.nih.gov/15579507/</ext-link> [cited 2021 May 11]</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Blank</surname> <given-names>V</given-names></string-name>, <string-name><surname>Andrews</surname> <given-names>NC</given-names></string-name>: <article-title>The Maf transcription factors: Regulators of differentiation [Internet]</article-title>. <source>Trends Biochem. Sci</source>. <volume>22</volume>: <fpage>437</fpage>–<lpage>441</lpage>, <year>1997</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9397686/">https://pubmed.ncbi.nlm.nih.gov/9397686/</ext-link> [cited 2021 May 11]</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Motohashi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Shavit</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Igarashi</surname> <given-names>K</given-names></string-name>, <string-name><surname>Yamamoto</surname> <given-names>M</given-names></string-name>, <string-name><surname>Engel</surname> <given-names>JD</given-names></string-name>: <article-title>The world according to Maf</article-title>. <source>Nucleic Acids Res. [Internet</source>] <volume>25</volume>: <fpage>2953</fpage>–<lpage>2959</lpage>, <year>1997</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9224592/">https://pubmed.ncbi.nlm.nih.gov/9224592/</ext-link> [cited 2021 May 11]</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Cordes</surname> <given-names>SP</given-names></string-name>, <string-name><surname>Barsh</surname> <given-names>GS</given-names></string-name>: <article-title>The mouse segmentation gene kr encodes a novel basic domain-leucine zipper transcription factor</article-title>. <source>Cell</source> [Internet] <volume>79</volume>: <fpage>1025</fpage>–<lpage>1034</lpage>, <year>1994</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/8001130/">https://pubmed.ncbi.nlm.nih.gov/8001130/</ext-link> [cited 2021 May 11]</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Takahashi</surname> <given-names>S</given-names></string-name>: <article-title>Functional analysis of large MAF transcription factors and elucidation of their relationships with human diseases</article-title>. <source>Exp. Anim</source>. <volume>70</volume>: <fpage>264</fpage>–<lpage>271</lpage>, <year>2021</year></mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Sadl</surname> <given-names>VS</given-names></string-name>, <string-name><surname>Jin</surname> <given-names>F</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Cui</surname> <given-names>S</given-names></string-name>, <string-name><surname>Holmyard</surname> <given-names>D</given-names></string-name>, <string-name><surname>Quaggin</surname> <given-names>SE</given-names></string-name>, <string-name><surname>Barsh</surname> <given-names>GS</given-names></string-name>, <string-name><surname>Cordes</surname> <given-names>SP</given-names></string-name>: <article-title>The mouse Kreisler (Krml1/MafB) segmentation gene is required for differentiation of glomerular visceral epithelial cells</article-title>. <source>Dev. Biol. [Internet</source>] <volume>249</volume>: <fpage>16</fpage>–<lpage>29</lpage>, <year>2002</year> Available from: https://pubmed.ncbi.nlm.nih.gov/12217315/[cited 2021 May 11]</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Zankl</surname> <given-names>A</given-names></string-name>, <string-name><surname>Duncan</surname> <given-names>EL</given-names></string-name>, <string-name><surname>Leo</surname> <given-names>PJ</given-names></string-name>, <string-name><surname>Clark</surname> <given-names>GR</given-names></string-name>, <string-name><surname>Glazov</surname> <given-names>EA</given-names></string-name>, <string-name><surname>Addor</surname> <given-names>MC</given-names></string-name>, <string-name><surname>Herlin</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Leheup</surname> <given-names>BP</given-names></string-name>, <string-name><surname>McGill</surname> <given-names>J</given-names></string-name>, <string-name><surname>McTaggart</surname> <given-names>S</given-names></string-name>, <string-name><surname>Mittas</surname> <given-names>S</given-names></string-name>, <string-name><surname>Mitchell</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Mortier</surname> <given-names>GR</given-names></string-name>, <string-name><surname>Robertson</surname> <given-names>SP</given-names></string-name>, <string-name><surname>Schroeder</surname> <given-names>M</given-names></string-name>, <string-name><surname>Terhal</surname> <given-names>P</given-names></string-name>, <string-name><surname>Brown</surname> <given-names>MA</given-names></string-name>: <article-title>Multicentric carpotarsal osteolysis is caused by mutations clustering in the amino-terminal transcriptional activation domain of MAFB</article-title>. <source>Am. J. Hum. Genet. [Internet</source>] <volume>90</volume>: <fpage>494</fpage>–<lpage>501</lpage>, <year>2012</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22387013/">https://pubmed.ncbi.nlm.nih.gov/22387013/</ext-link> [cited 2023 Jan 16]</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Zhou</surname> <given-names>B</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Rajagopal</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Domian</surname> <given-names>I</given-names></string-name>, <string-name><surname>Rivera-Feliciano</surname> <given-names>J</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>D</given-names></string-name>, <string-name><surname>von Gise</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ikeda</surname> <given-names>S</given-names></string-name>, <string-name><surname>Chien</surname> <given-names>KR</given-names></string-name>, <string-name><surname>Pu</surname> <given-names>WT</given-names></string-name>: <article-title>Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart</article-title>. <source>Nature [Internet</source>] <volume>454</volume>: <fpage>109</fpage>–<lpage>113</lpage>, <year>2008</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18568026">http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uids=18568026</ext-link></mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Matcovitch-Natan</surname> <given-names>O</given-names></string-name>, <string-name><surname>Winter</surname> <given-names>DR</given-names></string-name>, <string-name><surname>Giladi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Aguilar</surname> <given-names>SV</given-names></string-name>, <string-name><surname>Spinrad</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sarrazin</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ben-Yehuda</surname> <given-names>H</given-names></string-name>, <string-name><surname>David</surname> <given-names>E</given-names></string-name>, <string-name><surname>González</surname> <given-names>FZ</given-names></string-name>, <string-name><surname>Perrin</surname> <given-names>P</given-names></string-name>, <string-name><surname>Keren-Shaul</surname> <given-names>H</given-names></string-name>, <string-name><surname>Gury</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lara-Astaiso</surname> <given-names>D</given-names></string-name>, <string-name><surname>Thaiss</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Cohen</surname> <given-names>M</given-names></string-name>, <string-name><surname>Halpern</surname> <given-names>KB</given-names></string-name>, <string-name><surname>Baruch</surname> <given-names>K</given-names></string-name>, <string-name><surname>Deczkowska</surname> <given-names>A</given-names></string-name>, <string-name><surname>Lorenzo-Vivas</surname> <given-names>E</given-names></string-name>, <string-name><surname>Itzkovitz</surname> <given-names>S</given-names></string-name>, <string-name><surname>Elinav</surname> <given-names>E</given-names></string-name>, <string-name><surname>Sieweke</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Schwartz</surname> <given-names>M</given-names></string-name>, <string-name><surname>Amit</surname> <given-names>I</given-names></string-name>: <article-title>Microglia development follows a stepwise program to regulate brain homeostasis</article-title>. <source>Science [Internet</source>] <volume>353</volume>: <year>2016</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed-ncbi-nlm-nih-gov.proxy.insermbiblio.inist.fr/27338705/">https://pubmed-ncbi-nlm-nih-gov.proxy.insermbiblio.inist.fr/27338705/</ext-link> [cited 2023 Jun 8]</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Blanchi</surname> <given-names>B</given-names></string-name>, <string-name><surname>Kelly</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Viemari</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Lafon</surname> <given-names>I</given-names></string-name>, <string-name><surname>Burnet</surname> <given-names>H</given-names></string-name>, <string-name><surname>Bevengut</surname> <given-names>M</given-names></string-name>, <string-name><surname>Tillmanns</surname> <given-names>S</given-names></string-name>, <string-name><surname>Daniel</surname> <given-names>L</given-names></string-name>, <string-name><surname>Graf</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hilaire</surname> <given-names>G</given-names></string-name>, <string-name><surname>Sieweke</surname> <given-names>MH</given-names></string-name>: <article-title>MafB deficiency causes defective respiratory rhythmogenesis and fatal central apnea at birth</article-title>. <source>Nat Neurosci [Internet</source>] <volume>6</volume>: <fpage>1091</fpage>–<lpage>1100</lpage>, <year>2003</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/14513037">https://www.ncbi.nlm.nih.gov/pubmed/14513037</ext-link></mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Boerries</surname> <given-names>M</given-names></string-name>, <string-name><surname>Grahammer</surname> <given-names>F</given-names></string-name>, <string-name><surname>Eiselein</surname> <given-names>S</given-names></string-name>, <string-name><surname>Buck</surname> <given-names>M</given-names></string-name>, <string-name><surname>Meyer</surname> <given-names>C</given-names></string-name>, <string-name><surname>Goedel</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bechtel</surname> <given-names>W</given-names></string-name>, <string-name><surname>Zschiedrich</surname> <given-names>S</given-names></string-name>, <string-name><surname>Pfeifer</surname> <given-names>D</given-names></string-name>, <string-name><surname>Laloë</surname> <given-names>D</given-names></string-name>, <string-name><surname>Arrondel</surname> <given-names>C</given-names></string-name>, <string-name><surname>Gonçalves</surname> <given-names>S</given-names></string-name>, <string-name><surname>Krüger</surname> <given-names>M</given-names></string-name>, <string-name><surname>Harvey</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Busch</surname> <given-names>H</given-names></string-name>, <string-name><surname>Dengjel</surname> <given-names>J</given-names></string-name>, <string-name><surname>Huber</surname> <given-names>TB</given-names></string-name>: <article-title>Molecular fingerprinting of the podocyte reveals novel gene and protein regulatory networks</article-title>. <source>Kidney Int. [Internet</source>] <volume>83</volume>: <fpage>1052</fpage>–<lpage>1064</lpage>, <year>2013</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/23364521/">https://pubmed.ncbi.nlm.nih.gov/23364521/</ext-link> [cited 2023 Jun 9]</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="web"><string-name><surname>Bailey</surname> <given-names>TL</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>J</given-names></string-name>, <string-name><surname>Grant</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Noble</surname> <given-names>WS</given-names></string-name>: <article-title>The MEME Suite</article-title>. <source>Nucleic Acids Res</source>. [Internet] <volume>43</volume>: <fpage>W39</fpage>–<lpage>W49</lpage>, <year>2015</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25953851/">https://pubmed.ncbi.nlm.nih.gov/25953851/</ext-link> [cited 2023 Jun 9]</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>McLean</surname> <given-names>CY</given-names></string-name>, <string-name><surname>Bristor</surname> <given-names>D</given-names></string-name>, <string-name><surname>Hiller</surname> <given-names>M</given-names></string-name>, <string-name><surname>Clarke</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Schaar</surname> <given-names>BT</given-names></string-name>, <string-name><surname>Lowe</surname> <given-names>CB</given-names></string-name>, <string-name><surname>Wenger</surname> <given-names>AM</given-names></string-name>, <article-title>Bejerano G: GREAT improves functional interpretation of cis-regulatory regions</article-title>. <source>Nat Biotechnol [Internet</source>] <volume>28</volume>: <fpage>495</fpage>–<lpage>501</lpage>, <year>2010</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/20436461">http://www.ncbi.nlm.nih.gov/pubmed/20436461</ext-link></mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Lerdrup</surname> <given-names>M</given-names></string-name>, <string-name><surname>Johansen</surname> <given-names>JV</given-names></string-name>, <string-name><surname>Agrawal-Singh</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hansen</surname> <given-names>K</given-names></string-name>: <article-title>An interactive environment for agile analysis and visualization of ChIP-sequencing data</article-title>. <source>Nat. Struct. Mol. Biol. [Internet</source>] <volume>23</volume>: <fpage>349</fpage>–<lpage>357</lpage>, <year>2016</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26926434/">https://pubmed.ncbi.nlm.nih.gov/26926434/</ext-link> [cited 2023 Jun 9]</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Stewart</surname> <given-names>BJ</given-names></string-name>, <string-name><surname>Ferdinand</surname> <given-names>JR</given-names></string-name>, <string-name><surname>Young</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Mitchell</surname> <given-names>TJ</given-names></string-name>, <string-name><surname>Loudon</surname> <given-names>KW</given-names></string-name>, <string-name><surname>Riding</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Richoz</surname> <given-names>N</given-names></string-name>, <string-name><surname>Frazer</surname> <given-names>GL</given-names></string-name>, <string-name><surname>Staniforth</surname> <given-names>JUL</given-names></string-name>, <string-name><surname>Braga</surname> <given-names>FAV</given-names></string-name>, <string-name><surname>Botting</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Popescu</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Vento-Tormo</surname> <given-names>R</given-names></string-name>, <string-name><surname>Stephenson</surname> <given-names>E</given-names></string-name>, <string-name><surname>Cagan</surname> <given-names>A</given-names></string-name>, <string-name><surname>Farndon</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Polanski</surname> <given-names>K</given-names></string-name>, <string-name><surname>Efremova</surname> <given-names>M</given-names></string-name>, <string-name><surname>Green</surname> <given-names>K</given-names></string-name>, <string-name><surname>Velasco-Herrera</surname> <given-names>MDC</given-names></string-name>, <string-name><surname>Guzzo</surname> <given-names>C</given-names></string-name>, <string-name><surname>Collord</surname> <given-names>G</given-names></string-name>, <string-name><surname>Mamanova</surname> <given-names>L</given-names></string-name>, <string-name><surname>Aho</surname> <given-names>T</given-names></string-name>, <string-name><surname>Armitage</surname> <given-names>JN</given-names></string-name>, <string-name><surname>Riddick</surname> <given-names>ACP</given-names></string-name>, <string-name><surname>Mushtaq</surname> <given-names>I</given-names></string-name>, <string-name><surname>Farrell</surname> <given-names>S</given-names></string-name>, <string-name><surname>Rampling</surname> <given-names>D</given-names></string-name>, <string-name><surname>Nicholson</surname> <given-names>J</given-names></string-name>, <string-name><surname>Filby</surname> <given-names>A</given-names></string-name>, <string-name><surname>Burge</surname> <given-names>J</given-names></string-name>, <string-name><surname>Lisgo</surname> <given-names>S</given-names></string-name>, <string-name><surname>Lindsay</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bajenoff</surname> <given-names>M</given-names></string-name>, <string-name><surname>Warren</surname> <given-names>AY</given-names></string-name>, <string-name><surname>Stewart</surname> <given-names>GD</given-names></string-name>, <string-name><surname>Sebire</surname> <given-names>N</given-names></string-name>, <string-name><surname>Coleman</surname> <given-names>N</given-names></string-name>, <string-name><surname>Haniffa</surname> <given-names>M</given-names></string-name>, <string-name><surname>Teichmann</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Behjati</surname> <given-names>S</given-names></string-name>, <article-title>Clatworthy MR: Spatiotemporal immune zonation of the human kidney</article-title>. <source>Science [Internet</source>] <volume>365</volume>: <fpage>1461</fpage>–<lpage>1466</lpage>, <year>2019</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31604275/">https://pubmed.ncbi.nlm.nih.gov/31604275/</ext-link> [cited 2023 Jun 7]</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Courtney</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gjernes</surname> <given-names>E</given-names></string-name>, <string-name><surname>Druelle</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ravaud</surname> <given-names>C</given-names></string-name>, <string-name><surname>Vieira</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ben-Othman</surname> <given-names>N</given-names></string-name>, <string-name><surname>Pfeifer</surname> <given-names>A</given-names></string-name>, <string-name><surname>Avolio</surname> <given-names>F</given-names></string-name>, <string-name><surname>Leuckx</surname> <given-names>G</given-names></string-name>, <string-name><surname>Lacas-Gervais</surname> <given-names>S</given-names></string-name>, <string-name><surname>Burel-Vandenbos</surname> <given-names>F</given-names></string-name>, <string-name><surname>Ambrosetti</surname> <given-names>D</given-names></string-name>, <string-name><surname>Hecksher-Sorensen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ravassard</surname> <given-names>P</given-names></string-name>, <string-name><surname>Heimberg</surname> <given-names>H</given-names></string-name>, <string-name><surname>Mansouri</surname> <given-names>A</given-names></string-name>, <article-title>Collombat P: The inactivation of Arx in pancreatic alpha-cells triggers their neogenesis and conversion into functional beta-like cells</article-title>. <source>PLoS Genet [Internet</source>] <volume>9</volume>: <fpage>e1003934</fpage>, <year>2013</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/24204325">http://www.ncbi.nlm.nih.gov/pubmed/24204325</ext-link></mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Kirita</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>H</given-names></string-name>, <string-name><surname>Uchimura</surname> <given-names>K</given-names></string-name>, <string-name><surname>Wilson</surname> <given-names>PC</given-names></string-name>, <article-title>Humphreys BD: Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A. [Internet</source>] <volume>117</volume>: <fpage>15874</fpage>– <lpage>15883</lpage>, <year>2020</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32571916/">https://pubmed.ncbi.nlm.nih.gov/32571916/</ext-link> [cited 2023 May 1]</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Brunskill</surname> <given-names>EW</given-names></string-name>, <string-name><surname>Georgas</surname> <given-names>K</given-names></string-name>, <string-name><surname>Rumballe</surname> <given-names>B</given-names></string-name>, <string-name><surname>Little</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Potter</surname> <given-names>SS</given-names></string-name>: <article-title>Defining the molecular character of the developing and adult kidney podocyte</article-title>. <source>PLoS One [Internet</source>] <volume>6</volume>: <fpage>e24640</fpage>, <year>2011</year> Available from: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/21931791">http://www.ncbi.nlm.nih.gov/pubmed/21931791</ext-link></mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Motamedi</surname> <given-names>FJ</given-names></string-name>, <string-name><surname>Badro</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Clarkson</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lecca</surname> <given-names>MR</given-names></string-name>, <string-name><surname>Bradford</surname> <given-names>ST</given-names></string-name>, <string-name><surname>Buske</surname> <given-names>FA</given-names></string-name>, <string-name><surname>Saar</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hübner</surname> <given-names>N</given-names></string-name>, <string-name><surname>Brändli</surname> <given-names>AW</given-names></string-name>, <string-name><surname>Schedl</surname> <given-names>A</given-names></string-name>: <article-title>WT1 controls antagonistic FGF and BMP-pSMAD pathways in early renal progenitors</article-title>. <source>Nat. Commun</source>. <volume>5</volume>: <year>2014</year></mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Pogenberg</surname> <given-names>V</given-names></string-name>, <string-name><surname>Consani Textor</surname> <given-names>L</given-names></string-name>, <string-name><surname>Vanhille</surname> <given-names>L</given-names></string-name>, <string-name><surname>Holton</surname> <given-names>SJ</given-names></string-name>, <string-name><surname>Sieweke</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Wilmanns</surname> <given-names>M</given-names></string-name>: <article-title>Design of a bZip transcription factor with homo/heterodimer-induced DNA-binding preference</article-title>. <source>Structure [Internet</source>] <volume>22</volume>: <fpage>466</fpage>–<lpage>477</lpage>, <year>2014</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/24530283/">https://pubmed.ncbi.nlm.nih.gov/24530283/</ext-link> [cited 2023 Jun 9]</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>C</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>W</given-names></string-name>, <string-name><surname>Li</surname> <given-names>J</given-names></string-name>, <string-name><surname>Li</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kou</surname> <given-names>X</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>H</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>S</given-names></string-name>: <article-title>Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-implantation embryos</article-title>. <source>Nat. 2016 5377621</source> [Internet] <volume>537</volume>: <fpage>558</fpage>–<lpage>562</lpage>, <year>2016</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://www.nature.com/articles/nature19362">https://www.nature.com/articles/nature19362</ext-link> [cited 2021 Aug 20]</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Margueron</surname> <given-names>R</given-names></string-name>, <string-name><surname>Reinberg</surname> <given-names>D</given-names></string-name>: <article-title>The Polycomb complex PRC2 and its mark in life</article-title>. <source>Nature [Internet</source>] <volume>469</volume>: <fpage>343</fpage>–<lpage>349</lpage>, <year>2011</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21248841/">https://pubmed.ncbi.nlm.nih.gov/21248841/</ext-link> [cited 2023 Jun 9]</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Soshnikova</surname> <given-names>N</given-names></string-name>, <string-name><surname>Duboule</surname> <given-names>D</given-names></string-name>: <article-title>Epigenetic Temporal Control of Mouse Hox Genes in Vivo</article-title>. <source>Science (80-.)</source>. [Internet] <volume>324</volume>: <fpage>1320</fpage>–<lpage>1323</lpage>, <year>2009</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://science.sciencemag.org/content/324/5932/1320">https://science.sciencemag.org/content/324/5932/1320</ext-link> [cited 2021 Aug 20]</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Majumder</surname> <given-names>S</given-names></string-name>, <string-name><surname>Thieme</surname> <given-names>K</given-names></string-name>, <string-name><surname>Batchu</surname> <given-names>SN</given-names></string-name>, <string-name><surname>Alghamdi</surname> <given-names>TA</given-names></string-name>, <string-name><surname>Bowskill</surname> <given-names>BB</given-names></string-name>, <string-name><surname>Golam Kabir</surname> <given-names>M</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Advani</surname> <given-names>SL</given-names></string-name>, <string-name><surname>White</surname> <given-names>KE</given-names></string-name>, <string-name><surname>Geldenhuys</surname> <given-names>L</given-names></string-name>, <string-name><surname>Tennankore</surname> <given-names>KK</given-names></string-name>, <string-name><surname>Poyah</surname> <given-names>P</given-names></string-name>, <string-name><surname>Siddiqi</surname> <given-names>FS</given-names></string-name>, <string-name><surname>Advani</surname> <given-names>A</given-names></string-name>: <article-title>Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease</article-title>. <source>J. Clin. Invest. [Internet</source>] <volume>128</volume>: <fpage>483</fpage>–<lpage>499</lpage>, <year>2018</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29227285/">https://pubmed.ncbi.nlm.nih.gov/29227285/</ext-link> [cited 2023 Jun 9]</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Jeong</surname> <given-names>H-W</given-names></string-name>, <string-name><surname>Hernández-Rodríguez</surname> <given-names>B</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>J</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>K-P</given-names></string-name>, <string-name><surname>Enriquez-Gasca</surname> <given-names>R</given-names></string-name>, <string-name><surname>Yoon</surname> <given-names>J</given-names></string-name>, <string-name><surname>Adams</surname> <given-names>S</given-names></string-name>, <string-name><surname>Schöler</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Vaquerizas</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Adams</surname> <given-names>RH</given-names></string-name>: <article-title>Transcriptional regulation of endothelial cell behavior during sprouting angiogenesis</article-title>. <source>Nat. Commun. 2017 81</source> [Internet] <volume>8</volume>: <fpage>1</fpage>–<lpage>14</lpage>, <year>2017</year> Available from: <ext-link ext-link-type="uri" xlink:href="https://www.nature.com/articles/s41467-017-00738-7">https://www.nature.com/articles/s41467-017-00738-7</ext-link> [cited 2021 Aug 23]</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Pasquali</surname> <given-names>L</given-names></string-name>, <string-name><surname>Gaulton</surname> <given-names>KJ</given-names></string-name>, <string-name><surname>Rodríguez-Seguí</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Mularoni</surname> <given-names>L</given-names></string-name>, <string-name><surname>Miguel-Escalada</surname> <given-names>I</given-names></string-name>, <string-name><surname>Akerman</surname> <given-names>İ</given-names></string-name>, <string-name><surname>Tena</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Morán</surname> <given-names>I</given-names></string-name>, <string-name><surname>Gómez-Marín</surname> <given-names>C</given-names></string-name>, <string-name><surname>Bunt</surname> <given-names>M</given-names></string-name> <string-name><surname>van de Ponsa-Cobas</surname> <given-names>J</given-names></string-name>, <string-name><surname>Castro</surname> <given-names>N</given-names></string-name>, <string-name><surname>Nammo</surname> <given-names>T</given-names></string-name>, <string-name><surname>Cebola</surname> <given-names>I</given-names></string-name>, <string-name><surname>García-Hurtado</surname> <given-names>J</given-names></string-name>, <string-name><surname>Maestro</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Pattou</surname> <given-names>F</given-names></string-name>, <string-name><surname>Piemonti</surname> <given-names>L</given-names></string-name>, <string-name><surname>Berney</surname> <given-names>T</given-names></string-name>, <string-name><surname>Gloyn</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Ravassard</surname> <given-names>P</given-names></string-name>, <string-name><surname>Skarmeta</surname> <given-names>JLG</given-names></string-name>, <string-name><surname>Müller</surname> <given-names>F</given-names></string-name>, <string-name><surname>McCarthy</surname> <given-names>MI</given-names></string-name>, <string-name><surname>Ferrer</surname> <given-names>J</given-names></string-name>: <article-title>Pancreatic islet enhancer clusters enriched in type 2 diabetes risk–associated variants</article-title>. <source>Nat. Genet. [Internet</source>] <volume>46</volume>: <issue>136</issue>, <year>2014</year> Available from: /pmc/articles/PMC3935450/ [cited 2021 Aug 23]</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Zaret</surname> <given-names>KS</given-names></string-name>: <article-title>Pioneer Transcription Factors Initiating Gene Network Changes</article-title>. <source>Annu. Rev. Genet</source>. [Internet] <volume>54</volume>: <fpage>367</fpage>, <year>2020</year> Available from: /pmc/articles/PMC7900943/ [cited 2023 Jan 19]</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Lopez-Pajares</surname> <given-names>V</given-names></string-name>, <string-name><surname>Qu</surname> <given-names>K</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Webster</surname> <given-names>DE</given-names></string-name>, <string-name><surname>Barajas</surname> <given-names>BC</given-names></string-name>, <string-name><surname>Siprashvili</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Zarnegar</surname> <given-names>BJ</given-names></string-name>, <string-name><surname>Boxer</surname> <given-names>LD</given-names></string-name>, <string-name><surname>Rios</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Tao</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kretz</surname> <given-names>M</given-names></string-name>, <string-name><surname>Khavari</surname> <given-names>PA</given-names></string-name>: <article-title>A LncRNA-MAF:MAFB Transcription Factor Network Regulates Epidermal Differentiation</article-title>. <source>Dev. Cell</source> <volume>32</volume>: <fpage>693</fpage>–<lpage>706</lpage>, <year>2015</year></mixed-citation></ref>
</ref-list>
<sec id="s55">
<fig id="figs1" position="float" orientation="portrait" fig-type="figure">
<label>Suppl. Figure 1:</label>
<caption><title>Representation of ChIPseq tracks.</title>
<p><bold>A-B)</bold> Side-by side comparison of two independent ChIP-seq experiments at the <italic>Nphs1</italic> (podocytes specific) and <italic>Hoxc</italic> cluster showed highly reproducible results. All further analyses were therefore performed with merged datasets. C-G) Examples of actively repressed developmental genes: <italic>paraxis</italic>, <italic>Gata4</italic>, <italic>Dmrt1</italic>, <italic>Six2</italic> and <italic>Hoxd</italic> genes cluster, dotted line in G indicate the separation of active and inactive genes of the cluster. Colour scheme: H3K4m3 (green), H3K4me1 (blue,) H3K27me3 (red) and the Input (raw sonicated chromatin, grey).</p></caption>
<graphic xlink:href="555670v1_figs1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs2" position="float" orientation="portrait" fig-type="figure">
<label>Suppl. Figure 2:</label>
<caption><title>WT1 ChIP-seq analysis.</title><p><bold>A</bold>) Schematic illustration of the glomerular isolation procedure used for ChIP experiments. B) Distribution of WT1 peaks shows a large proportion (42.29%) of peaks to map to promoter regions (&lt;1kb). C) <italic>De novo</italic> MEME analysis of the top 1000 enriched regions identified a core sequence highly similar to the previously identified consensus sequence for WT1 binding. D) Overlap between newly identified and previously published WT1 binding regions. E-F) GREAT analysis identifies ‘<italic>focal segmental glomerulosclerosis</italic>’ and ‘<italic>abnormal renal glomerulus basement membrane thickness’</italic> as highly enriched GO terms.</p></caption>
<graphic xlink:href="555670v1_figs2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs3" position="float" orientation="portrait" fig-type="figure">
<label>Suppl. Figure 3:</label>
<caption><title>Validation of the RNA-seq analysis.</title><p>A) qPCR analysis showed absence of <italic>Mafb</italic> and significant reduction of <italic>Nphs2</italic> expression 48hours after tamoxifen induction (n=5, ****p&lt;0.001, **p&lt;0.01). B) Pearson correlation and C) hierarchical clustering of samples. D) Volcano plot revealing the spread of down-and up-regulated genes in <italic>Mafb<sup>cko</sup></italic> glomeruli.</p></caption>
<graphic xlink:href="555670v1_figs3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<fig id="figs4" position="float" orientation="portrait" fig-type="figure">
<label>Suppl. Figure 4:</label>
<caption><title>MAFB expression pattern during podocyte maturation.</title><p>A) Immunofluorescence staining shows that MAFB is not detectable at the early stage of nephrogenesis (vesicle stage, arrowhead), but it appears at the very first steps of podocyte differentiation (comma shaped bodies/precapillary loop stage, asterisk) and remains expressed in adult podocytes. Scale bar: 100µm. B) Single cell analysis in developing human kidneys. Dotted lines identify the early expression of <italic>MAFB</italic> in proximal S shaped bodies, comparable with the one of <italic>WT1</italic> and slightly earlier than <italic>TCF21</italic> compared with the appearance of late podocytes markers <italic>NPHS1</italic> and <italic>NPHS1</italic></p></caption>
<graphic xlink:href="555670v1_figs4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p><bold>Suppl. Table 1:</bold> Histone methylation peaks detected by ChIP-Seq analysis</p>
<p><bold>Suppl. Table 2:</bold> ChIP-Seq peaks for MAFB and WT1</p>
<p><bold>Suppl. Table 3:</bold> RNA-Seq analysis</p>
<p><bold>Suppl. Table 4:</bold> List of Primers</p>
</sec>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.93138.1.sa2</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Daehn</surname>
<given-names>Ilse S</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Icahn School of Medicine at Mount Sinai</institution>
</institution-wrap>
<city>New York</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Incomplete</kwd>
<kwd>Solid</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>This study presents <bold>valuable</bold> insights into the epigenetic landscape in adult kidney podocytes. A series of <bold>solid</bold> experiments demonstrate that genes that are regulated by a key kidney transcription factor, Mafb, are essential for H3K4me3 methylation and recruitment of Wt1 to Nphs1 and Nphs2. This new information provides insights into the potential relationship and coordination of transcription factors in regulating target genes in podocytes in glomerular diseases, although the conclusion that MafB is generally required for Wt1 to bind to podocyte-specific promoters is <bold>incomplete</bold> and should be extended beyond two or three genes.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.93138.1.sa1</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>
In their manuscript, Massa and colleagues provide a map of the epigenetic landscape in podocytes and analyze the role of the transcription factor MafB in podocyte gene expression. They initially map the histone profile in adult podocytes of the mouse by assaying three different histone methylation marks, namely H3K4me3, H3K4me1, and H3K27me3 for active, primed, and repressed states. They then perform Wt1- and MafB-ChIP-Seq analysis to identify respective direct targets of those transcription factors. Subsequently, they employ an inducible MafB knockout model and show that homozygous knockout mice show proteinuria and FSGS, suggesting an important role for MafB in podocyte homeostasis. RNA-Seq analysis in mice two days after tamoxifen application identified direct and indirect MafB target genes. Finally, the authors turn to a constitutive MafB knockout model, carry out anti-H3K4me3 and anti-Wt1 ChIP experiments, and examine selected promoters. One main conclusion from this work is that MafB opens chromatin and thus facilitates the binding of other transcription factors like Wt1 to podocyte-specific genes.</p>
<p>Strengths and weaknesses:</p>
<p>
The authors have performed an impressive number of experiments and generated very valuable data. They use state-of the-art technology and the data are presented well and are sound. This being said the manuscript contains significant novel data, but also experiments that are already available in some sort. The histone profile in adult mouse podocytes is novel and provides an interesting map of epigenetic marks in this particular cell type. It is maybe not too surprising that podocyte-differentiation genes have different chromatin accessibility than genes associated with general development. The Wt1-ChIP has been done before by several labs but is certainly an important control in this work. The MafB-ChIP is new. The inducible MafB knockout model including the identification of Tcf21 as a target gene has been published by others in 2020 (and is acknowledged by the authors). The experiments addressing the potential role of MafB in chromatin opening are new. I find that the data are certainly compatible with the model put forward by the authors, but they are not compelling.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.93138.1.sa0</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>
The authors investigate the role of MafB in regulating podocyte genes. Mafb is required for podocyte differentiation and maintenance. Mutations of this gene cause FSGS in mice and humans. They profiled MafB binding genome-wide in isolated glomeruli and defined overlap with Wt1. They provide evidence that Mafb is required for Wt1 binding and H3K4me3 methylation at the promoters of two essential podocyte genes, Nphs1 and Nphs2. Understanding how the action of different transcription factors is coordinated to control gene expression - the main goal of this paper - is an important line of investigation.</p>
<p>While the main conclusion of the paper is supported by their data, the scope is limited. Additional ChIP-seq experiments and data analysis are needed to solidify and extend their conclusions.</p>
<p>Strengths:</p>
<p>1. Performing ChIP-seq for histone modifications on isolated podocytes provides valuable cell-type-specific information. Similarly, profiling Mafb and Wt1 in isolated glomeruli provides podocyte-specific binding patterns because these transcription factors (TFs) are not expressed in other cell types in glomeruli. The significant overlap of their Wt1 binding genome-wide with that of prior published work is reassuring. RNA-seq on isolated podocytes provides the appropriate cell-type specific gene expression data to integrate with ChIP-seq data. Together, the RNA-seq and ChIP-seq data are valuable resources for other investigators examining gene regulation in mouse podocytes.</p>
<p>2. The phenotype analysis of their FSGS model is convincing and well done.</p>
<p>3. Testing how Wt1 binding is affected by loss of Mafb provides insight into how these key podocyte TFs may cooperate to regulate genes.</p>
<p>Weaknesses:</p>
<p>1. The conclusion that Mafb is required for Wt1 binding and H3K4me3 methylation is based solely on ChIP-PCR at two gene promoters (Nphs1, Nphs2). This result should be validated and extended by ChIP-seq. Mafb and Wt1 binding overlap at more than 200 sites. If their model is correct, it is likely that Wt1 binding would be affected at other genomic sites. This result would add strong support to their model of how Wt1 and Mafb cooperate to regulate genes in podocytes. Moreover, ChIP-seq would define whether the dependence of Wt1 on Mafb is also evident at distal regulatory regions (defined H3K4me1, which is typically found at predicted enhancers).</p>
<p>2. The FSGS model generated by the authors involved conditional deletion of Mafb in podocytes at 8 weeks of age. They found that this resulted in reduced expression of Nphs1 and Nphs2 within 48 hours post-deletion. However, they investigated Wt1 binding and H3K4me3 genomic binding in Mafb homozygous null embryos. While this result provides information about podocyte differentiation, it does not address the maintenance of expression of these essential podocyte genes in the adult kidney. Because post-natal deletion of Mafb led to FSGS and reduced expression of Nphs1/2, ChIP-seq should be performed on the adult conditional mutants in order to provide mechanistic information about the disease.</p>
<p>3. H3K4me1 binds enhancer regions. The authors performed ChIP-seq to profile H3K4me1 in isolated podocytes. However, there was no analysis reported of these results. It would be valuable to determine if Wt1 and Mafb co-localize at predicted enhancers in podocytes and if Wt1 binding is lost at these regions in Mafb mutant glomeruli.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.93138.1.sa3</article-id>
<title-group>
<article-title>Author Response</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Massa</surname>
<given-names>Filippo M.</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jian-Motamedi</surname>
<given-names>Fariba</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Šerys</surname>
<given-names>Marijus</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tison</surname>
<given-names>Amelie</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Loubat</surname>
<given-names>Agnès</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lacas-Gervais</surname>
<given-names>Sandra</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martin</surname>
<given-names>Luc</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Belahbib</surname>
<given-names>Hassiba</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sarrazin</surname>
<given-names>Sandrine</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sieweke</surname>
<given-names>Michael H.</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schedl</surname>
<given-names>Andreas</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<disp-quote content-type="editor-comment">
<p><bold>eLife assessment</bold></p>
<p>This study presents valuable insights into the epigenetic landscape in adult kidney podocytes. A series of solid experiments demonstrate that genes that are regulated by a key kidney transcription factor, Mafb, are essential for H3K4me3 methylation and recruitment of Wt1 to Nphs1 and Nphs2. This new information provides insights into the potential relationship and coordination of transcription factors in regulating target genes in podocytes in glomerular diseases, although the conclusion that MafB is generally required for Wt1 to bind to podocyte-specific promoters is incomplete and should be extended beyond two or three genes.</p>
</disp-quote>
<p>We thank the reviewers and editors for critically reading our manuscript and their insightful comments. We will strive to revise</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1 (Public Review):</bold></p>
<p>Summary:</p>
<p>In their manuscript, Massa and colleagues provide a map of the epigenetic landscape in podocytes and analyze the role of the transcription factor MafB in podocyte gene expression. They initially map the histone profile in adult podocytes of the mouse by assaying three different histone methylation marks, namely H3K4me3, H3K4me1, and H3K27me3 for active, primed, and repressed states. They then perform Wt1- and MafB-ChIP-Seq analysis to identify respective direct targets of those transcription factors. Subsequently, they employ an inducible MafB knockout model and show that homozygous knockout mice show proteinuria and FSGS, suggesting an important role for MafB in podocyte homeostasis. RNA-Seq analysis in mice two daysafter tamoxifen application identified direct and indirect MafB target genes. Finally, the authors turn to a constitutive MafB knockout model, carry out anti-H3K4me3 and anti-Wt1 ChIP experiments, and examine selected promoters. One main conclusion from this work is that MafB opens chromatin and thus facilitates the binding of other transcription factors like Wt1 to podocyte-specific genes.</p>
<p>Strengths and weaknesses:</p>
<p>The authors have performed an impressive number of experiments and generated very valuable data. They use state-of the-art technology and the data are presented well and are sound. This being said the manuscript contains significant novel data, but also experiments that are already available in some sort. The histone profile in adult mouse podocytes is novel and provides an interesting map of epigenetic marks in this particular cell type. It is maybe not too surprising that podocyte-differentiation genes have different chromatin accessibility than genes associated with general development. The Wt1-ChIP has been done before by several labs but is certainly an important control in this work. The MafB-ChIP is new. The inducible MafB knockout model including the identification of Tcf21 as a target gene has been published by others in 2020 (and is acknowledged by the authors). The experiments addressing the potential role of MafB in chromatin opening are new. I find that the data are certainly compatible with the model put forward by the authors, but they are not compelling.</p>
</disp-quote>
<p>We agree that additional data on changes in chromatin accessibility in the absence of Mafb would help to support our model and we will be working towards this data for a revised version of the manuscript.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2 (Public Review):</bold></p>
<p>Summary:</p>
<p>The authors investigate the role of MafB in regulating podocyte genes. Mafb is required for podocyte differentiation and maintenance. Mutations of this gene cause FSGS in mice and humans. They profiled MafB binding genome-wide in isolated glomeruli and defined overlap with Wt1. They provide evidence that Mafb is required for Wt1 binding and H3K4me3 methylation at the promoters of two essential podocyte genes, Nphs1 and Nphs2 Understanding how the action of different transcription factors is coordinated to control gene expression - the main goal of this paper - is an important line of investigation.</p>
<p>While the main conclusion of the paper is supported by their data, the scope is limited. Additional ChIP-seq experiments and data analysis are needed to solidify and extend their conclusions.</p>
<p>Strengths:</p>
<p>1. Performing ChIP-seq for histone modifications on isolated podocytes provides valuable cell-type-specific information. Similarly, profiling Mafb and Wt1 in isolated glomeruli provides podocyte-specific binding patterns because these transcription factors (TFs) are not expressed in other cell types in glomeruli. The significant overlap of their Wt1 binding genome-wide withthat of prior published work is reassuring. RNA-seq on isolated podocytes provides the appropriate cell-type specific gene expression data to integrate with ChIP-seq data. Together, the RNA-seq and ChIP-seq data are valuable resources for other investigators examining gene regulation in mouse podocytes.</p>
<p>1. The phenotype analysis of their FSGS model is convincing and well done.</p>
<p>1. Testing how Wt1 binding is affected by loss of Mafb provides insight into how these key podocyte TFs may cooperate to regulate genes.</p>
<p>Weaknesses:</p>
<p>1. The conclusion that Mafb is required for Wt1 binding and H3K4me3 methylation is based solely on ChIP-PCR at two gene promoters (Nphs1, Nphs2). This result should be validated and extended by ChIP-seq. Mafb and Wt1 binding overlap at more than 200 sites. If their model is correct, it is likely that Wt1 binding would be affected at other genomic sites. This result would add strong support to their model of how Wt1 and Mafb cooperate to regulate genes in podocytes. Moreover, ChIP-seq would define whether the dependence of Wt1 on Mafb is also evident at distal regulatory regions (defined H3K4me1, which is typically found at predicted enhancers).</p>
</disp-quote>
<p>We agree that a genome wide analysis of chromatin accessibility would help corroborating our model and will work towards this data for a revised version.</p>
<disp-quote content-type="editor-comment">
<p>1. The FSGS model generated by the authors involved conditional deletion of Mafb in podocytes at 8 weeks of age. They found that this resulted in reduced expression of Nphs1 and Nphs2 within 48 hours post-deletion. However, they investigated Wt1 binding and H3K4me3 genomic binding in Mafb homozygous null embryos. While this result provides information about podocyte differentiation, it does not address the maintenance of expression of these essential podocyte genes in the adult kidney. Because post-natal deletion of Mafb led to FSGS and reduced expression of Nphs1/2, ChIP-seq should be performed on the adult conditional mutants in order to provide mechanistic information about the disease.</p>
</disp-quote>
<p>The fact that the phenotype in Mafb conditional mutant animals is progressive means that epigenetic changes are also likely to be quantitative. Indeed, Nphs1/Nphs2 are still expressed 6 weeks after Mafb deletion, albeit at lower levels. Since ChIP-seq experiments are not necessarily quantitative, we believe it may be difficult to detect statistically significant changes in this model. We will discuss this limitation of our study in a revised version of our manuscript.</p>
<disp-quote content-type="editor-comment">
<p>1. H3K4me1 binds enhancer regions. The authors performed ChIP-seq to profile H3K4me1 in isolated podocytes. However, there was no analysis reported of these results. It would be valuable to determine if Wt1 and Mafb co-localize at predicted enhancers in podocytes and if Wt1 binding is lost at these regions in Mafb mutant glomeruli.</p>
</disp-quote>
<p>We well reanalyse the data taking the reviewer’s comments into account.</p>
</body>
</sub-article>
</article>